Content-Type: text/html

#

    Reference sequence (query): batch____
    Identities normalised by aligned length.
    Colored by: property

    HSP processing: ranked
    Search cycle: 3

                                                                                                          1 [        .         .         .         .         :         .         .         .         .         1         .         .         .         .         :         .         .         .         .         2         .         .] 221
        batch____                                              bits   E-value  N 100.0%   1:221             MLDLFKAIGLGLVVLLPLANPLTTVALFLGLAGNMNSAERNRQSLMASVYVFAIMMVAYYAGQLVMDTFGISIPGLRIAGGLIVAFIGFRMLFPQQKAIDSPEAKSKSEELEDEPSANIAFVPLAMPSTAGPGTIAMIISSASTVRQSSTFADWVLMVAPPLIFFLVAVILWGSLRSSGAIMRLVGKGGIEAISRLMGFLLVCMGVQFIINGILEIIKTYH
      1 UniRef50_A3P530        MarC family integral membra...   169     7e-41  1  27.4%   4:218 195:405     ---LISEILFGFTGLMGIINPFGIAFLFLERTESLTEAQRAALARKVAINAFIVLLAAFFVGTPILHFFGISLEALRIGGGLAVAVAGWQMLNEPDVPT---GGDTAAQPVEPRNAMARAFFPLTIPLTTGPGSIATAIALNANRTHKLSEFVLSSIVSVAVS-ALAALVIWQTYSRAAFLARYLGTEGTKVAMRVSAFLLLCVGVQIMLTGFSEFLR---
      2 UniRef50_A8AGR9        UPF0056 inner membrane prot...   165     1e-39  1  92.8%   1:221   1:221     MMDLFKAIGLGLVVLLPLANPLTTVALFLGLAGNMNSAERNRQSLMASVYVFAIMMVAYYAGQLVMNTFGISIPGLRIAGGLIVAFIGFRMLFPQQKAHESPEAKSKSEELEDEPSANIAFVPLAMPSTAGPGTIAMIISSASTVRHGVDFPGWVILVAPPLIFLAVSVILWGSLRSSGAIMRLVGKGGIEAISRLMGFLLVCMGVQFIINGVLEIIKTYH
      3 UniRef50_C6X9P4        Multiple antibiotic resista...   165     1e-39  1  26.9%   2:220   1:209     -MSEWAYLFKTGIALFAIVNPVGSVPIFISATDGWSPKDRARTAKTVGLTVFVVLMTSAFLGNGILDFFSISIPSFQVGGGILVMLIAISMMHGKQSHARQ----TPEEAQAVAEREVIAIVPLSIPLLAGPGAISSMIITAQKHSGFW------GHVSLIVPVAAVCLLIWLTLRLSSAIAHKLGTLGINIVTRLMGLILAAMAVEFIAQGISGLFPGL-
      4 UniRef50_D1CJ06        Multiple antibiotic resista...   163     4e-39  1  23.5%   5:221   1:208     ----MNFFLKALVALFTIVDPIGMAPIVVGLTAHLSPAVRRRVVTRATLIATGVVAVFALFGKPLLEFLGITPEAFSIAGGALLFLVSIDMLFGRESGAR----ETGREAREARTREDISVFPLAIPLIAGPGTITTVILLMDSAQGHASR-----QLAVAAAVAIVMFCTWVSMSLAFPIQKRMGTTGTLVLSRVLGMLLAAIAIQYILNGLSSFAESLR
      5 UniRef50_A3IQE6        Multiple antibiotic resista...   162     9e-39  1  27.6%   5:221   3:209     ----FSEYINSFITLLAISNPIGNLPIYLGLTADKTKKQRQQTIKTASIAFAIILIVSCFMGEVILSAFGISIASFRVAGGFLIFIFGFHMLQAKTSDIHH----TSEENQDAQTADSIAIVPLALPLLAGPGTISSVIVLAHKTQ------SLVEKLGLSIVIIILAILIFISYSFAHVIGNFLGKTGMNIVTRLMGLITMAMAVQFMADGLEVLFPGWK
      6 UniRef50_A8HXT9        Multiple antibiotic resista...   161     1e-38  1  25.9%   1:220   1:223     MSQFINIFVAVFAALFPIVNPLGGAPIFYEMTRACAPQVRASLAMKVAIYGFILLVVSLVAGSRILTFFGISLPVLRVAGGLVVTFVGWNILHQGDASAEKAPDATATRDVDVLRVEQQAFYPLTMPLTMGPGSIATAIALGSQgpADGYGHMIIEAMGALSGIAAVSASVYFAYRYASDIERFLGPNGTNVLVRLFAFILLCIGMQIMWLGIRDLVASL-
      7 UniRef50_B6IWJ1        MarC integral membrane fami...   159     5e-38  1  26.5%   2:220   1:209     -MEPWSEYSRFIVALFAMLTPFAAIPIFLGLTEGRTDAERNRTAASAALTVFSVLAGSAFLGNAVLAVVGTSLDSFRVGGGIVLLLIALSMLNATVSAVKQ----TPTEADEAASRHAIGVVPLGLPLLAGPGSISAVII------ETQRGSGWEHTAIIVGSITLVCLFIWLSLRLAVPIGRMMGRTGLNIMNRLFGLLLAAVAVEIISTGLRNLFPGW-
      8 UniRef50_C1D8X8        Probable multiple antibioti...   159     6e-38  1  29.9%   7:220   2:205     ------EVFKIFIALLVLVNPIGAIPIFISLTPNSTAEERQRIALTTSKAVAIVTVTFALLGETILKFLNISVGSFQVGGGILMMLIAIAMMNAKQTPTKT----TRQEQEEAEFKTNIAVVPLAIPLMTGPGTMSTIIIYASTSH------DWIELVMLLLACGLIAVTCYVALRAATPISRMLGQTGINIVNRVMGMVLAAVSVEVIVNGLYRLFPML-
      9 UniRef50_Q13TQ7        Multiple antibiotic resista...   158     1e-37  1  31.3%   8:221   3:206     -------ILKSFISLLALINPVGAIPFFMSLTAHQSDAERRRTIRIAAISVFCVIAVTTLLGQQIIAFFGISVGSLEVGGGIIMLLMAINMLNAQIGNSRS----TPEERHEAEQKDNIAVVPLAIPLLTGPGAISTTIIYAAGSAHWYDRISLVAIGAVLAAI------CFFSLRLAEPIARWVGRTGINIGTRLMGLMLSALAVEFIVDGLKALLPNLK
     10 UniRef50_D0KYA2        Multiple antibiotic resista...   158     2e-37  1  32.6%   1:215   1:209     MPDLMHHALTAFMAFLAMMNPVANAVIFLGLTADMGLATTRHVAWRAVRTAFFIVLTFALFGPLVFSLFGITLPALRVAGGVLIALVGFRMLHGENSRVSHPKQIPSESGSEVDSSqdIAITPLAIPVLAGPGTIATAMSYSPSGH-------WMQTGATILMFTLICALTFYAFVFSERILARIGRGGVAVITRLMGLILAVIGVQMLLDGLHQ------
     11 UniRef50_C1D7D3        Probable multiple antibioti...   158     2e-37  1  25.8%   8:220  11:223     -------FLFALAALLPIINPPGLIPIFLSLTSRNTREQRQFLARRIAIYGFVLLAGSMFIGSYLLSFFGVSLPVVQLGGGLLLTFTAWRMLNDTP--AEHSTHAPEPEHIDQAQLKQRAFYPLGFPLTVGPGSVSVSITIGATFFHSNHNFVQLAlvASLLAVAVVCYLIYFCYLHAETMLHHLGPTGAVVFLRLSAFILVCLGMQIMWNGISELISGW-
     12 UniRef50_O32244        UPF0056 membrane protein yv...   156     6e-37  1  26.3%   4:220   2:209     ---MFSFIVHVFISLFAVSNPIGNVPIFLTLTEGYTAAERKAIARKAAILSFFILAAFLVFGHLIFKLFDINIHALRVAGGIFIFGIAYNLLNAKES---HVQSLHHDEHKESKEKADISVTPLSIPIIAGPGTIATVMSLSAGHSGIGH------YAAVMIGIAAVIALTFLFFHYSAFISSKLGKTEMNVITRLMGLILAVVAVGMIGAGLKGMFPVL-
     13 UniRef50_A0NQU3        Putative uncharacterized pr...   155     9e-37  1  25.5%   4:219   1:211     ---MLDYYINAFATLFVTIDPVGLAPMFLAITAGMSKHDRRKVAVRATITAAGILLVFYASGQTVLNVLGISVSAFRVAGGILLFLIAIEMIFGKRQARKTETAEKAMeeAHHGTINELAIFPLAIPLISGPAAISAIILLSSQAPDT------LAYAGLGGVIAIILLSCMGAFLLADKIERLLGETAQLVITRLLGVLLAALSVQFVADGILAFIRT--
     14 UniRef50_Q7NUG9        Probable multiple antibioti...   154     1e-36  1  23.2%   1:220   4:224     LSTFITKFLFVMAALLPIMNPPGLVPIFISMTARNTPQQRRYLARRIAIYCALLLVGSMFVGGYVLSFFGVSLPVVQMSGGLLITFAAWRMLNDTPAESSQPSAEQARVDSQAELKQ-RAFYPLTFPLTVGPGSVSVAITIGATLTGSGKGLvvISPIAGLSAVLVGSTLVYLCYANADKLLRYLGQTGSVVFLRLSAFILLCLGVQIMWDGFGELASQW-
     15 UniRef50_A0B911        Multiple antibiotic resista...   154     2e-36  1  23.6%   4:219  22:226     ---YLQYFVYVFTSLFIIVSPIEATMVFVSLTQDASPAERDRICVRTTLVAFSIAMVFALAGDMILRFFGITVDSLRVAGGILLFLVAIDMLRAKP-----HKKVTQAEIEDATTREDISIFPLAIPLLTGPGTITTVIVHMGASNT------LPEKMIVLLAICLTFGATYAILKSAEHIHDILGVTGIMVFTRILGLILGAIAVDFVSVGAWNIYIS--
     16 UniRef50_O66819        UPF0056 membrane protein aq...   153     3e-36  1  26.1%   1:218   6:213     MEEFGVLFVKAFLSLLAIMNPFSSVPVVISLMNEYSKEEIRVIALKASVYAFFILTFFLISGDLLFRFMGITLPAFKVGGGILLFLIALNLVQGEVT----KEKGKAHEIEAALRRDNIALIPLAMPLLAGPGSITTVLVL------RGYLNTLEGKVALFCAIFLSSFTAFVVYSLSTFFYRVLGRTGINLITRISGILLLAISVQFVVDGLKNLLK---
     17 UniRef50_Q2IJJ0        Multiple antibiotic resista...   153     4e-36  1  23.4%   1:218   1:206     MKPLLDYGLLVFVSMFTMMGPVGVLPPFVSMTSGLSGDEARRVARRATITALCVLLVFALGGQLVFRFFNISVNSLRVVGGIILLLVGYEMLQARPSRTKH------DEPAPEGYAEDIAITPLGIPVIAGPGAITTVIILMSEAH------DLARKAVLLVVLLGLHVLTYAMLVSAKPLLAFLGPSGNKVLVRIMGLIVMVIAVEFFFAGLKPIVR---
     18 UniRef50_B4U7Z6        Multiple antibiotic resista...   153     4e-36  1  29.4%   3:220   8:215     --DIIYFIIKFSISIFAILNPFGALPVLVSLTKGYTKEDRSYVIRTSSIYAGLTLIFFVLFGDLLFEIFGIGLGAFQIGGGIILSFVSINMIFGQP----HRERASNQELEEAEQKENIAIVPIAIPLLAGPGAISTVITIASSYR------SVFYHVLLILSILVACIGVFLVFKSVDKIVKILGKIGINILSRLMGILLMSLAMQFIIKGIQLAFPTL-
     19 UniRef50_Q0C4W2        Membrane protein, MarC fami...   153     4e-36  1  20.8%   2:217   3:213     -PELISLFTAAFVTFFVLIDAPGVAPIFATLTAKGSPAYRRKMAYKSVFVATIIMLLFAFGGAWLLDAMHISIDAFRAAGGVLLFLIALDMVFEKRTERREQRADEveEHRNDPEPEDVSVFPMGIPMIAGPGSIATAMFYMTEAE------SIAHQGVVLAAIGANLLITLIIFLLATPIVRLMGASVAGALTRILGVILAALSAQLILDGIRGAF----
     20 UniRef50_Q1IWE7        Multiple antibiotic resista...   152     6e-36  1  30.9%   3:219   5:212     --ELSSISLQTFLTMLVVMDPIGLAPIFIGLAGNRPSFERRRMALRASVVAGVIILCFGLFGRGLLDHLGISLSAFRVAGGILLFLIALDMVFARPSGSK----ETPEEGQEAQERQDISVFPLAIPLIAGPGTLASIMILAGDAHGNP-----ALLAAVFVVTFLVLLLCYLALRLSGQIARVIGVTGVHVVTRVLGVLLGALAVQYVADGALEFLRG--
     21 UniRef50_C1CXZ5        Putative multiple antibioti...   152     8e-36  1  29.0%   3:219   6:213     --QFLTTINKTFLTMLVVMDPIGLAPIFIGLASNRPRFERQRVAFKATLVAGIIILMFGLFGRDLLKHLGISLSAFRIAGGVLLFMIALDMVFARPSGSK----ETPEEEQEAHERQDISVFPLAIPLIAGPGTLASIMILAGDAHGEP-----LLLGGVFSVTFLVLLLCYLALRLSGQIARVIGLTGVHVVTRVLGVLLGALAVQYIADGTLELLRG--
     22 UniRef50_C1DAG1        Probable multiple antibioti...   152     8e-36  1  26.7%   4:220   8:222     ---FASKVLFVIAALFPILNPPGHAPLFLSLTVHNTPEERAILARKVGIYSFMLLLPSMFIGSYVLRIFDITLPFVQVGGGILVAIAAWEMLADKHGP--SPEEQAEPHQLDQNALSQRAFYPITFPITVGPGSITVAITVGASMQGKGLESFTLLPLASFVAVSLIAYSLYWSYRYADRLLRLLGPNGTMVFLRLSAFILMCLGVQIFWEGLTQLILQF-
     23 UniRef50_C5U4I6        Multiple antibiotic resista...   152     1e-35  1  23.7%   4:218   2:205     ---DIQYFIISFTSIFSILNPIGAVPIFISLTESYPEKERILVAKKTVIYAFSILLAFAVFGEYILKFFGISIEAFKIGGGILLLLIALDMVRGKQESKIHKR-----EIKEADEVDEIALMPLATPLLAGPGSITAVMVAMAEAPSFEDR------IFVILAILISIFITYLTFVFSERIIDKLGRLGTRILTRLMGLILTAIAVQMILTGYLGVVR---
     24 UniRef50_A7JXE2        Multiple antibiotic resista...   151     1e-35  1  26.9%   1:219   1:210     MKELIVHTVTVFMGFFAIMNPIANIPIFLSLTADEDKETVRSMALRSVFIAFVIIAIFSIAGKLIFDLFGITLYALRITGGILVFLIGFNMLQGDSTHQKTKEKAYSPAQQQAA--LSIAVSPLAMPILAGPGTIATAMNFAT-------AGGFDQTIITIVSFAVLCVITYILFLFGDKLVKAVGPSALNVVTKMMGLILAVIGTQMFIDGAGEAYKT--
     25 UniRef50_D1JHZ5        Conserved hypothetical memb...   151     1e-35  1  25.6%   2:220   4:213     -TTLVGFLCTCLGGYFAIMNPIANTPVFISLTQGDDAATKKAVARNSILFAFVLIAFLSFAGNFIFKLFGITQPALQITGGIIIFMIGYHMLQGSGSKAHTPSD--DDIESSRKARLNVAISPLGIPILAGPGTIAVAMGYAAGFE-------LIHVILSLLAFGVICGITYLCFRGSEEIVEHLGQNGLNVITRLMGLCLAAIGTGMVLSGLGADIHTF-
     26 UniRef50_B5EJL1        Multiple antibiotic resista...   151     2e-35  1  25.0%   5:220   7:212     ----LHSALQTLIALLAILNPVGAIPIFIALTSDEDPQQRLATAKLASRAVAVVLLTSAFLGEYILQFFGISIAAFQVAGGMVLMLLAFNMLQAKSSRYRH----TPEEAAEGMQKEAVAVVPLAIPLLAGPGTMVTVII------AHHKNASWLASGLLIIDILVIAGVAYAALRLAEPLSRRLGVTGINISTRIFGLVLAAIAVTFIANGLAALFPGL-
     27 UniRef50_Q1Q2V4        Putative uncharacterized pr...   151     2e-35  1  25.6%   2:220   1:209     -MEHWTEYTRFLTALMVILDPFAAIPIFLSLTQGYSQSQRARVVLVTIITVALVLISSAISGESLLKTFGTSLASFRVGGGIVLFIMALAMLRAQADKVKTSP----TEEAAAENKATIAVVPLAIPLLAGPGSISTVIIEMHRSSATYHGA------LVILCILITCILLWIVLRLASPIGRALGPIGRNILNRLFGLILTAIAIEIIANGLRELFPSL-
     28 UniRef50_D1BXK0        Multiple antibiotic resista...   151     2e-35  1  24.7%   4:218   6:209     ---DVALFIEVFVTLFVIMDPPGSVPVFLALTSRMTPKQRNRAARQAILVAFGVIVVFAAFGQQLLQYMGITLPALQASGGLLLLFVAMELLTGKM----------EEPEPAKGGAVNVALVPLGTPLLAGPGAIVATMVFV-QRRLEADEPVLAHWAAIVLAVIAVHLCVYLAMRFANTIQRILKDSGVTLVTRIAGLLLAAIAVQMIATAVTEFVR---
     29 UniRef50_B2JWZ3        Multiple antibiotic resista...   149     6e-35  1  26.7%   3:219  18:232     --QFGETVLLVVAGLFPVINPPAAGFIVLSLVPHATEKERAFLARSISINSLVILLVSLSIGAYVLSFFGISLPALRVAGGLVIAFAGWNLLHEQADTDREPDQAPAHDVSREVSLRSKAFYPLTLPITVGPGSIAVAVALGTGRPRGG--IAWIHLAGVLVALALLWASIYLCVRFAANLEKLLGPVGTEIAMRLFAFVLFCIGVQILWLGVDDLLES--
     30 UniRef50_B2IEA6        Multiple antibiotic resista...   149     6e-35  1  25.6%   4:218   1:208     ---MFPYLLQTFTTLFVVVDPLAMAPLFIAVTAGLTPVERRIVGRRACLSALFILLGFALLGETLLTVTGISLQAFRIAGGILLFWIAFEMVFHKRSDRKSAEVA-RTERPDETEILGLAVFPIAMPLIAGPGAIAAVIVATTHAPNTTAF------FGVIVLIIAIMAMTFVVLQIADRIDAFMGPTGRAVISRLLGVLLSALAVQIAIDGVHGLIP---
     31 UniRef50_A6KWY6        MarC family integral membra...   149     9e-35  1  27.2%   1:217   1:205     MDTLLPFALLCFTSFFTLTNPLGTMPVFLTMTKGMDDEERRHIVKRATIISFITLLAFTFSGQFLFKFFGISTNGFRIAAGFIILKIGYDMLQARFTNTKLKDEEIKTYA------NDISITPLSIPMLCGPGAIANGIMLMDDANT------WTMKGILIGIIGLIYFITYLILRASTRLVSILGETGNNVMMRLMGLILMVIAVECFVSGFRPIL----
     32 UniRef50_Q03GN0        Multiple antibiotic transpo...   147     2e-34  1  25.3%   2:218   1:206     -MNLVQAFLLSFTAFFAIMNPFANLPMFVSLTADNNRKEVDAIARLAFIVATVIVALFALLGNYIFSIFGINLSALRIMGGIILGLIGYHMIQGNVSPIQHDPKQSVKDSINSNNT-DVAISPLAMPVLAGPGTIATTMNLSSSTNP----------FIVISAFVVLSVITYFIFIYGEQIMAKLGNNIMNVITKLMGLILATIGVRMLIMGVQVAFH---
     33 UniRef50_A9A830        Multiple antibiotic resista...   147     2e-34  1  24.3%   4:217   2:212     ---DVQFIILAFTSLFSILNPFGVIPTYLVLTSQYSKVEKIKIIRKSMLAAFTILMMFALLGNQIIGFFGISIPAIKITGGVLLFLIALDMIQGNTSKVEKSPKLEShhSEEIEEMNEIAIVPLTVPLLTGPGSISAVIAMMAQTN------DFDGKISVIIAISLCIIISYFVLKFSKDLERILGKIGFKVLTKMMGLVLTAISIQMALDGILMVF----
     34 UniRef50_C8WCE4        Multiple antibiotic resista...   147     2e-34  1  23.3%   4:218   1:207     ---MISLFISTCISLFVVIDVPGCAPIFASLTKNATSTEQRTMAIRAVLVSSGILVFFGFLGESFLRAVGIGLAAFRIAGGILVLLTAIEMVFEKRTQKREDRARQVKKIPE--EAEDISVFPMAIPMIAGPGSIATIMLLISKTEN------WEQRITVFGALGAIQIMMVISLILAGPIMRVLGRRAEAMITRVLGLILAALAIQFILDGLKEFFH---
     35 UniRef50_B4ETK1        Multiple antibiotic resista...   147     2e-34  1  61.7%  25:220  28:222     ------------------------VALWLGLSGNMTKEQRNQQSFMACVYIFIIMTIAFYAGRVIMTTFGISIPGLRIAGGMIVAFIGFSMLFPHTPNVDDPLSEEKNPHRNPQAP-NIAFVPLAMPSTAGPGTIAMIISTAASIPSRTDIAQWVLYVAPITTFFLISLIVWLSLRGSTGIMRYLGHSGIDAISRVMGFLLICMGVQFMINGVLEIIADL-
     36 UniRef50_Q58382        UPF0056 membrane protein MJ...   147     2e-34  1  24.8%   2:219  17:224     -MDILNFYIYGFVSLFITIDPIGLIPIVHSLTYPYPKEQRIRIIKKAIISSTVVLLLFALFGNYIFGYFGITIDAFRVAGGILLFKIAWDMLHAEIPKTKHKP----DERLDLEDIDSIVYVPLAIPLISGPGAITTTMILISKTQ------SILEKGVVVLSILSAMLVSGIILSLTDFIIRRVNIYGINAFVRIMGLLLVAISVQIIFTGIVGLYNS--
     37 UniRef50_B5JMP6        Putative uncharacterized pr...   147     2e-34  1  22.2%   1:216   1:206     MGSSLEFLLLSTVSIFTIVNPFSAVPAFLAITPGESVVERRRSARLACLIAVCLLILTAVLGEFIFSLLGITLPALQIAGGVLLFSIGFEMVRAPDAPKR----LNETESDLAKEKEDISVTPLAVPLLCGPGSVSTVIILQGQTTSMMESS------MLLVSIVVVFVACYLILSASAKGGEWLNPILMRILRRVMGLLFAVIAVQFVVNGVGDL-----
     38 UniRef50_C1D6U8        Multiple drug resistance pr...   147     2e-34  1  30.9%   4:220   7:214     ---FSQYFLGAMLSFVVITNPLSKIPMFLSLTPGQTPVQKNRVAFTACAYAGAIMVVSLIGGNLVLSMFGISYGALRVAGGLVVAGVGYKMLYQAHDSTSHAHRES----------VDVSFFPLAMPGISGPGTIAVVIGFSTeaEITDWRWKIAAILITLGAIGGTMLVVWLSLKLSAKIAERIGPSALDVLTRLMGFLLICIGVQFVGSGIRTFYSTL-
     39 UniRef50_B9XPN0        Multiple antibiotic resista...   147     2e-34  1  22.3%   2:216   1:205     -MSLFEYTLLAGSSLFVIVDPVATVPAFIAMTPHDTPEQRIKTARLACFVMAGVLLSFAAAGRVIFKLMGITMPAFQIAASIVLLLVALDMLRAQ----RSRVQETHEETEAGAEKADIAVTPLAIPMLAGPGAISTAILLQNQAKTAAQHA------AVYVCILGVSFASYLILKVSARGAKWLNPIAMNVAIRIMGLLLAAVAIQFGLNAFKTL-----
     40 UniRef50_B6JA04        Putative membrane protein n...   147     3e-34  1  28.0%   3:220   6:218     --EIVNAFLLVYAALFPVINPVGGAPIFLRLTNRTPKARLPSLARGVAINSFVLLLCSLFIGSHVLVFFGITLPVLRIAGGLVVAALGWRLLHQGDDLEGRDQPAPREKEVD-------AFYPLTMPLTVGPGSISVAITLGSQRPSSalAQLAALGGGAATGLAAIAATIYVCYRFAGNIVTVLGERGTNVMMRLSAFLLFCIGIQIIWGGLRTLLPQL-
     41 UniRef50_Q1GI30        Multiple antibiotic resista...   147     3e-34  1  27.9%   2:216   1:203     -MIDTAFLITSFVTLFVIIDPIGLMPVFLALTQGMTSKQRRAIAIRASITGIGILAVFALFGESVLGFIGISMPAFRVAGGILLFLTALDMLFERRTARRQHQG------DEIAPEDDPSVFPMAIPLIAGPGSIATVILLTGQHPGIEGFASVMAIVVAVIALMLGM------FSISGALERLLGPVGINVATRLLGMLLAALSVQFVLDGLSAF-----
     42 UniRef50_Q7NGH4        Gll3195 protein n=1 Tax=Glo...   147     3e-34  1  27.5%   1:218   1:208     MRPMWESVLgtFLALLPVTDPLGAVPIFYSLTSSGSDSYRRRQARLTTIHVLWLLAGFLLVGKVVLEFFGISFAVLRIAGGLLIAQTGWEMVN--------SHRHEGDTALAANTSGDIAFAPMAMPLVSGPGAIGVVIGLSSKASG------WPDYFGSLVGIALVAGVLYLCLMLGEPLLKRLGRAGTRALNQILGFLILAIALQFMVDGLRELLR---
     43 UniRef50_A8GDQ2        Multiple antibiotic resista...   147     3e-34  1  80.0%   1:220   4:224     ILQLFQAIGLGLVLLLPLANPLTTVALLLGLSGNMTREERNQQSLMASVYVFFIMTVAFYAGQLVMNTFGISIPGLRIAGGLIVAFIGFRMLFPQQSADEAPEVESKSKELRKKTSANIAFVPLAMPSTAGPGTIAMIISSASSveNTLGFAHWVLLVAPVAIFLSVALILWACLRSSGAIMRLVGQSGIEAISRLMGFLLVCMGVQFIINGILEIISTY-
     44 UniRef50_B5I9R7        Multiple antibiotic resista...   146     4e-34  1  22.4%   4:217   2:202     ---DVNTFLHIFIPLFAVIDPFAALPLYMSLTTGLSETQKRKIVKEASLTAIVLLIFFAFLGIYILDFMGISIEALMIAGGLLMLLVSLEMVKEGDKPRSTKKKVALHEET-----GDIGIVPLGTPMLAGPGAISLVIILMSKYPTEWDSIVISIVGIIIL--------TALIFLGSNLISKIMGEKGSRAFTRVMGLLVAAFAVQYILDGVAQYF----
     45 UniRef50_B9JF99        Multiple antibiotic resista...   146     4e-34  1  27.3%   2:217   1:207     -MASADTLINAFTTLLVTVDPPGLAPLFIGLTAGMNRAERKQVALRGSLIAFFILAAFALFGASVLGILGISIGAFRIAGGLLLFWIAFEMVFEKRQDRKEK---TTEVAITKDHIHNIAVFPLALPLIAGPGAISATILLAGSLQTTFDRAQ------LIGVIAVNLGLVFAALAISDRLDRMLGATGRAILTRLLGVILAALAAQFVVDGVRSAL----
     46 UniRef50_B4WGQ9        Putative uncharacterized pr...   146     4e-34  1  25.9%   1:220   3:220     IRDFADFILGSIAALFPVMDPIGSVPVFLVLTAGVPQSLRHSYARRIALNVIFLLISFLLVGGGILRFFGISLEVVRIAGGIVVFHAAWNTMNA---ESKMSELENQDAAQKAGEHKDISFMPMTIPLLAGPGSIAVVLGLAAEarGAGTVETAQNLLAVVIAIGLIGLIIYVALRSSSLLLKWLGAGGIQALSRLLGLFVMAIGVQLILSGLGDWIESL-
     47 UniRef50_B9NN29        Putative uncharacterized pr...   146     4e-34  1  23.3%   6:220   4:209     -----TLAVGFFGALFAIMNPVTNLPVFLSVTQDLSVADQRKVAIKTATYCLILGTAFAAVGSQALSLFGISVNDLRVAGGLVVLMIGFNMLSGNESTSHHGTDGEKESYPAA---DTVAFYPLAFPILVGPGTITTLILYAHHVKTT------VDIFVYAGVFLAILALLLITFWNAAWLAKRLSANARVIMSRFMGMILAAIAISMIADGLKVLLPGL-
     48 UniRef50_D2RH21        Multiple antibiotic resista...   146     5e-34  1  20.8%   2:213   4:204     -VDYISYFVTAFTTIFVIVDPPGNIPFFIALTERFSEKERDRVSKKSTLIACALLIIIALSGDILLKFFHISIESLKVAGGILLFVIAIDILLGGARKEFYAKRGLKH-----IDVDSLAVFPIALPLYTGPGAITATIVLSAEA------SDIPSKILLIASIALVYIIVRLTHVYSEVVIKVLGKSGSDIVARVMAIFLAAIGVEYVFSGL--------
     49 UniRef50_B5ZPR0        Multiple antibiotic resista...   146     5e-34  1  27.3%   2:217   1:207     -MASADQLINAFTTLIVTIDPPGLAPIFLGLTTGMSRAQRTQVALRGSTIAFIILAVFALFGASVLGVLGISIGAFRIAGGLLLFWIAFEMVFERRQERKEKATEAA---VTKDHIENIAVFPLALPLIAGPGAISATILLAGTLPTSVEKAQF------IAVIAANLLLTFLMLLIADRLDRFLGVTGRAILTRLLGVILAALAVQFVVDGAKAAL----
     50 UniRef50_A8FYJ7        Multiple antibiotic resista...   146     6e-34  1  28.4%   1:218   1:217     MDGLWLHLGTVFMGFFAIMNPIANVPIFLGLTSEEDEQTTKAIAFRALLLAFIIITVFALMGQFIFTLFGISLSAFRITGGFLVFLIGFHMLQGNNSSVHHPDSAQVEESKAkeAALSIAVSPLALPILAGPGTIATAMSFSA-------VGGVAEMLITIGTFGALCVVTYLFFIFGGRLVNYLGSAALGAITRMMGLILAVIGTQMAIEGIKGAFA---
     51 UniRef50_B0C1W1        Multiple antibiotic resista...   146     6e-34  1  24.7%   2:220   1:215     -MFDLPEYLKLVAGLASIVNPVGVIPIFLSLTEGQGSSQRRLIAFQSSIALSIVLLVALVAGEAILSFFSISLPSFRVAGGLLILLTALSMLRAETIESRQLTETGTVDPNEPPTLPdvAVVPIAIPLLGGPGAISTVIVYAHTQE------SIEHTILVGLAILSVSVIALVGLLIAPLMDTVMGKTGMNVISRVMGLIITAISIEFIADGVKELLPGL-
     52 UniRef50_A7HDJ2        Multiple antibiotic resista...   146     7e-34  1  25.3%   1:217  14:222     MGELLSLGFVSFSAIFFVVDPFSAVPFFLAMTRRHSAEERRVIALRASIAAGVVLAGFALAGAWVFKLLGISLGAFKIAGGVVLLLLALDMIRTQPSRTR----ITEGEVEAGADKEDIAIVPLAMPLLAGPGGIATAVVLMARARGGP----WWHALPVLVAIALTAAASYAILAGATRTEKVLGRTGLAILERAAGLLLVAIGIQFMLDGLSESF----
     53 UniRef50_Q11TX7        Multiple antibiotic resista...   145     9e-34  1  34.9%   5:219   1:204     ----MDLIFATVAALLPIINPFSTAPMFLSLTQGDTKSYRNAQATQGVIYMLAILLVSLVGGSFIMNFFGLSMPGMRIAGGILVAGVGMKMLKPNDEI-----ETTEAETKEAENKKDISFTPLAMPSLSGPGSISVVIGMSSLAKNISDYCYIA------LGIIFVACVVLLVLRSSVGLVKVLGVNGLHAMTKIMGFLILCVGIQFIIHGTMDILTG--
     54 UniRef50_A5WGW0        Multiple antibiotic resista...   145     1e-33  1  25.3%   4:220   1:212     ---MDTEIVKIILAFVVLINPFSALTLFLDSTRGYSMTDKRRFARISSLTVFITIAFFTVAGETLLKVLGISVGSFQIAGGVLVFLIAINMMNGEGNPVknQENVEVDDSFESIGSTAAAVVPLAIPMMVGPGGISTVIIYSAQ------VTGWQQKLAIIIAGLLISIFCYLALMAAGQLSRFLGDTGLNIISRIMGMLLAAVAIEILVNGIKTVFPGL-
     55 UniRef50_Q2FNQ4        Multiple antibiotic resista...   145     1e-33  1  24.7%   2:220   3:214     -PDLISFSLFALSSILIVVNPLGALLVYNSITEFMDSKDKRKVAAYGCRIAGAVLIFFTLFGSSLLSLFGITISAFTVAGGVLLFGIGMEMVYARTSRAK----VTATEKYESIDAEDISSMPLAFPMISGPGTITTVIVLSQDTPIFSEPVEL---GIILGSVIVTILITYIVLISSEQITKRIGQREYRVVNRLMGIMLMAIAVQFIINGISQAFPML-
     56 UniRef50_B1ZWU7        Multiple antibiotic resista...   145     1e-33  1  38.3%   4:217   7:209     ---FWELILGTVIALLPLINPLASAPTFLAITDGDTPERRNQQLRMACLYTVGILVSFLIGGTFIMGFFGLSIPGLRIAGGLLVAGIGSHMLMSPPKPATDDPV-----HAAARAKRDISFSPLAMPMMSGPGSIAATISFTSLARG------WIDYVAIILGIIIVTVITYVTLRISDRVVRVVGFNSMNALSQVMGFLILCIGIQFVVNGVTEIV----
     57 UniRef50_Q8TW39        Integral membrane protein o...   145     1e-33  1  23.1%   8:219  11:202     -------VLKGVIELFVVVDPIGNVPALLAVTSELRPRDRVRVVHRAVAFAAVLILGFAVAGKATLDYLGISVEALMIAGGILLLRAAFGMVEGDPTGFR----------IEPGSHIDVAYVPLGTPLLAGPGAIVTVIVMLHRH----------GRLETILACLIVMLLTLVTFRAAERLARFLGRSGIRVLTRVMGVLLAAIGVQMVLDGVSAFVRG--
     58 UniRef50_Q11II0        Multiple antibiotic resista...   144     1e-33  1  28.0%   2:219   8:216     -MPPYDAILNAFTTLLVTVDPPGLAPLFLALTAGMNRQERHQVAIRACLISLGVLVLFALAGSSILSVLGITIPAFRVAGGMLLFVIAFEMIF---ERRQQRHKRSAERAITRDMIHNIAAFPLAIPLTAGPGAISATLLLSGTASAPGAR------LVMVAILLVVILITYLVFVLAERIDRFLGETGRSILTRLLGLLLSALAVQFVADGARELIQN--
     59 UniRef50_A5FN26        Multiple antibiotic resista...   144     2e-33  1  33.3%   4:219  22:228     ---FMDLFIYLFAALFSVLNPIGTVPIFVGLTQHDSQKERSRISLWTAINVGIILLVSYFIGQYVLTFFGISIDALRIAGGIVIVNSGFSLLSGKF---NKKRGINKKIENEVQQRNDIALTPLAIPMLAGPGSISLLIAFYQEHHQMEE------ILFSCLAILAIAVVIFVILKSAHYLARILGASGIVAISRIVGFIVISIGIQYIVSSIVNIIKG--
     60 UniRef50_Q8DGX4        Tlr2188 protein n=1 Tax=The...   144     2e-33  1  28.2%   1:220   1:207     MQPLLTFLLGTIAALFPITDPIAAIPVFYALTAKQSRRQRLKQARQVAINVAAVLTVFFFMGKLILAFFGISLPVVRIAGGLIVGHTAWQMV-------TSQDRLTQQEHIEAADKVDISLTPMAIPLISGPGAIAMTISLSTRCHT------WLEYLGAWLGILLLSAMVYLFLILGEPLSRAWGITDRGALTRLLGFLILAIAVQFIADGSLALLQTL-
     61 UniRef50_B5EBI8        Multiple antibiotic resista...   144     3e-33  1  21.5%   3:221   7:215     --THMEQLIVFVVQLFVIVDPLAAVPIFLAITVSHTKQERRSIARRGCSIGLLAIVFFLVAGPSLLRYFAINTSAVQISGGLLLFVIALELLYGNPTGTQT----SSKEERLAEKKEDVSVTPLAIPLLAGPGAIVTCLVFSSQASDA------LSVLILIGGAVIVFSAAYLLLHWADELARIFGELGMKVAVRIIGLILAFIAVQYVINGITALWPAVK
     62 UniRef50_Q1IU42        Multiple antibiotic resista...   144     3e-33  1  25.8%   4:216   9:210     ---IVQFTLVALSSVFFLVDPFAIIPTFLVMTARHDPITRRRMAARACWTAFIVLTAFAFAGTAIFKIFGITLPAFEIAGGLILLLIGLDMMQAER-----PTQEGSPETAEGSVKDDVSITPLGIPMLAGPGAISTVMVLNGTAR------DWSTTIPVFAAIALTCFASYWILRGAERVSQKMGQTGIRVLMRIMGLLLMAIAIQFMINGLTNL-----
     63 UniRef50_Q0A888        Multiple antibiotic resista...   144     3e-33  1  26.4%   1:220   1:212     MLVLLEYLIITFVAVFVIVNPLTTSFVFMALLPTASARRRRTIARRATVIATALFFLFATLGGLIFQIFGITLAAFRIAGGLILFGVAMAMI--RQTLPSEAETAEQARNDEGRITDDISVIPLAIPFISGPGAIATVMILTSEAPT------LYHLALVYLAVLSCTVTCYFAMIYSRHIVRFLGDTGKEILTKIFGLILAVLAIQFVINGVSDAVTGY-
     64 UniRef50_Q1H467        Multiple antibiotic resista...   143     3e-33  1  31.8%   1:220   3:216     ILEALKYISIVVIGLLPIMNPLTTIPLYMALTQRMTPETRKLQARKACIYAFFILTTFLLLGNGIIALFGISMAGIRVAGGLIILILALRMIFSGLDSSSSVDSEPEEIKSAN---LDYSFSPLAMPSLAGPGSIAVVMSFGSQIPEGSH---LIGDPIVIAGIAITIGIAYLALSSATHIEKMLGEHGMQAVTKIMGFLLTCVAVQFLASGIRDFYIEF-
     65 UniRef50_Q59071        UPF0056 membrane protein MJ...   143     4e-33  1  25.7%   4:217   2:204     ---DLQYFILAFSSIFSILNPFGAVPVFITLTESYPKKERDLVAKKTVIYALAILLAFALFGEWILKFFGISLDAFKIAGGILLLLISLDMVRGQQEAKIHR-----KEIEAAYEIDEIALMPLATPLLAGPGSITACMVAMAEASDIGD------KFLVILAILLSLGITYLTLLSAESVLDRIGRLGIRILTRMMGLILTAIAVQMIVNGIRGAL----
     66 UniRef50_B2S4M5        Hypothetical integral membr...   142     6e-33  1  19.7%   2:219  80:277     -MSTWTHIWSTAFTLLFIIDPIGNIPVVLSVLRTVPAERHTRIIFRELLLGLVLMLSFLFCGKVFLSLFQLETGVMKMAGSVILFLVGIKMVFPDQ------------HALPSTTEEEPFIVPIATPMIAGPSAFTTLVIMGETKGTSR--------LATCAALLVAWTLACLIMISAPCLYRLLKEKGITALERITGILLLILSIQMCVEGARGIIAT--
     67 UniRef50_O28169        UPF0056 membrane protein AF...   142     7e-33  1  25.5%   4:215   6:206     ---YLSFFFASFTTLFIIIDPPGNLPIFIALTERFSDEYREKISKRATIIAFLILFITMVTGGKILDYFGVSISSLKIAGGILLFISSVDILLGG-----TRREAYKRRAEESIDVDSIAVFPLALPLYTGPGAITAGIVLYSQAG------DVVMKLLVVLSAALVYSIVRLSHIYSAPIIRLLGRSGADIAARILAIFLAAIAVEFVFDGLAE------
     68 UniRef50_D1JFE0        Membrane protein, MarC fami...   142     9e-33  1  26.8%   4:216   2:203     ---DYAYAVSVFIAIFAIVNPLGNIAFFTTLTQDYSKAEKKKVATKAIIAATATLIIFALVGRYIFVLFNITIPAFRIAGGLLLLMIAFSMLYGTTPGTKS----TEKEKQESVEKEMVGVIPLGIPMLAGPGAISTVMLYISHGN-------IWDALIVFISVFATMAVTYIFLANADRIFNRVGRVGSLAISRIMGLILATVAIQFLINGTHEI-----
     69 UniRef50_B8GXJ6        MarC family integral membra...   141     1e-32  1  22.4%   2:220   1:218     -MTEANLAVNFFVALFALIDPIGNVPLFAAATLGAAAAGRRMVAVYIGLFMAAFLIFFYFTGVGLLEFFGISMPAFRIAGGIILFILGLDMVRDDFTTMFADAAEGIEDQSpaKQRFERLIVPFAMPLLIGPGSISTVIIYAAEAKDFGA----AGMGIGVAVIAAVSLVTVLTFWASPLVSKVLGRIGMSIVVRVLGLILCALAVQFVLVGVADATRGL-
     70 UniRef50_C7JEW2        Multiple antibiotic resista...   141     2e-32  1  26.0%   2:216  16:230     -TSSISSFLLAFPALFSIVNPFGAALIFAQATAGRSQTEIMALARLVSFYSLCLIMASLWLGSMVLAFFGITVNALRVAGGLVVAVRAWDLLQSPEtaQKEKQALQGGRTVMAPNWADAAFFPLAMPFTVGPGTIAVAIALGSGCP--ADEPFWAYTIGTTLAGVCVVAIVWAAYSGADKLVSMLGVTGTRIVSRMAALVLLCIGVQILAAGVQGF-----
     71 UniRef50_A4SSK7        Multiple antibiotic resista...   141     2e-32  1  41.9%   4:218   2:206     ---FFQVVFLALLALLPMVNPPTTATLLLGLSKGMSREHVRRQVNLAAIYLFFTLCITFFIGSSILDLFGISIPGLRLAGGLIIGFIGFRMLFPAPSQTN-----------GVDINQSIAFVPLTMPSMCGPGTMALVISGAAqaELPDEYNRLTIYGAMVTAFALMSLISWGVLKLADPVCKILGATGIDAMTRIMGFLLVCMGMQFCINGIKEVAQ---
     72 UniRef50_Q3DS24        Integral membrane protein o...   141     2e-32  1  24.7%   4:185   1:168     ---MISKFILAFMAFFAIMNPISNLPAFMALVADDDQKISRRIAAKGVLLAFVIIVIFVLSGHLLFNLFGITLAALKISGGILVGIIGYKMINGIHSPT------NKNLEEHKDDPMNVAVSPLAMPLLAGPGTIATAMGLSS--------GGLSGKLITILAFAILCVIMYVILISANEITKFL------------------------------------
     73 UniRef50_A0KDA2        Multiple antibiotic resista...   141     2e-32  1  23.8%   4:217  28:232     ---DLTFSIKVFAALFAIMNPIANIPVFLSLTEGAADGVRRKVALTAAIGVTVGCIVSAVAGGAILHVFGLTIDDFRLAGGLLVLLIALSMLHGAPSRQHAP---GADESADPAAADSVAIYPLTIPLLVGPGTIATMIVLGHGAVATGQEFAFALGLAAFLVLLAVSLL------SAPLIGHYLSPRVTAVTQRLMGMILAAIAMQMIVASLKAAF----
     74 UniRef50_Q6L1H0        Multiple antibiotic resista...   141     2e-32  1  24.4%   2:218   1:208     -MNYAYLFISSLVTLFAIMNPIGAVPILIALTDGYTKDERNNVILKSVFTAAGMMLGFMLIGVYIFQVLRISIYDFEIAGGMLLFKVAFDMLQGRTSPTK----ITSTEKEESVEREAIGVAPLGTPLLAGPGTITTAIIF-----FNGNGNAIMTRFVVIMSVIILIILTYIILKFSIPIFARLGKTGSIVITRIMGLLLASIGVQLVASGIINVFH---
     75 UniRef50_B2KEY3        Multiple antibiotic resista...   141     2e-32  1  26.4%   4:219   2:215     ---DFSFLIGAFVGTLSILNPIGNVPIFLEHVQTDSPKMQRAIALLLGLSIFALLIFFFFIGRSALNLFSITIPAFRIAGGILILLVGIRMMQGKseGIQAAPAAQQNVFEEATFRLSSIIVPVAMPLFVGPGTITTVILFSDNTKT------LLNTVGMVLVLAICSAIVTICLLSSRYIYKILGNNGMQIVVRFMGMILCAMAVQFMIDGFAQLLPG--
     76 UniRef50_Q11V88        Putative uncharacterized pr...   141     2e-32  1  23.1%   1:221   1:209     MSIDWSFALVVFTGLFAIINPIGNAPIFISFVDHLDKHQQKAIALKSVTVGFIILAIFVVFGYALFNVFNISIQAFRITGGLLVLKVGFDMINSKPKDAATLVKNSEATDT------GFAISPLATPILVGPGTLSTAVSFVGVGNKIENSIIIICSSAIILTI------TYFVFISSTTLIAKIGKEALNVVTKIMGLLIASIGIQMIITSIEELIHNYK
     77 UniRef50_Q26F85        Multiple antibiotic resista...   140     3e-32  1  25.5%   1:220   1:206     MDDLLTFAFTVFTGFFAIMNPISNMPIFLTITEGADKETKQRINLKAIIVAFIIVSTFVLLGNYIFELFGITIPAFKITGGILIFFVGFEMLQSKKSNIKRLKTVNYDE--------NIAISPLAIPILAGPGTIVTATNFVANTSSYAD------IAVVLLVFALMCLLNYIAFSLSDVIAKKIGDNVISVIGKLMGLIIAIIGTSMIISGLKLSFDVL-
     78 UniRef50_B8F4B7        Multiple antibiotic resista...   139     5e-32  1  22.7%   4:219   1:203     ---MFDSLVVQFVVLWAVIDPIGSIPVYLAKTVGLSPEDRRKIARNAILIAAGILLFFLVLGQWLLDAMQIPLSAFQIAGGLVLLLFALTMIFG--------ESKPDQEIKMKSNLHELAVYPLAVPSIASPGAMMAVVLLTDNHRY-----SFGDQVITTGIMLSVLLITYILFLVANRIQHFIGHAGAAIISRVMGLILSAVAINNILLGLKDFITQ--
     79 UniRef50_B6R883        Putative uncharacterized pr...   139     6e-32  1  23.7%   6:220  24:227     -----TALITYVAALFSMMNPIGNTGVFAGMTADRDAATARRIAWTCAGAIALTLLTVTWTGGILLKFFGITVHELRAAGGVIVLLIALSMLRSDNSHRQTPQ-----EAASAAEQNHIAVVPLAIPIVAGPGAIATAIVAAERHSGIW------AKIDLSIAAVGLALFTGFLFSVSKPIANKLGESGMGVVTRLMGMVLAAIAMGMLADGVKGMIPAL-
     80 UniRef50_A4SWC9        Multiple antibiotic resista...   139     6e-32  1  29.0%   5:218   6:219     ----LASFVTVFAALFPVINPLGDGPIFLNMVQGCSEGVRNKLARSVSVNCFFMLLASMLIGPQLLLFFGISLPALKLAGGAVVIAMGWNLLNQK---SASDKGANESTGITDETSDGSAFFPLTMPLTVGPGSIATAIALVAAYQESSSFseLPAVIGTVAALFALSLTIYFIYRESSGIQRIFGVNGTNVLMRLFAFILLAIGVQIFLGGINGYLE---
     81 UniRef50_C0DXR4        Putative uncharacterized pr...   139     8e-32  1  25.2%   4:221   1:211     ---MITHILYLFTGLIVLNNPLIALGYFVDKTAGFTLKEQRKTARLVSISAFICMVVAGVIGTPLLKVLGIGIPAFQIAGGILVFVIAMSMMGGEDNPVK-PNLNKEHSSLPPEKQFAFAVVPMATPIIVGPGGFSIVIIYSSHVGT------WQGALELLIACFMVGVTCYLILAGSARLSKILGNVGIKIINRVSGLLLAAIAVEIVLAGLRSLFPALK
     82 UniRef50_C7RRV2        Multiple antibiotic resista...   139     9e-32  1  29.0%   1:221   1:211     MDPTLTLFISLFTTLLAIINPLEAIPVYLGLMENRPESEQRQVARRACFYATLLSFFFLIFGTLLLRVFEVPLSMVRVVGGVILTRVGFELFAPPPSGGLIPRSGGNDT--------DVAFVPLAMPIMFGPGAIATLISMASTIKQSAEE--LIYFLAASLAIIACLGTTYISLIYAKPILRKIGTQGIDAATRIVGFFVAAMGMGLIFNGAVEFLESYR
     83 UniRef50_A9W5P7        Multiple antibiotic resista...   138     1e-31  1  27.8%   2:217   8:222     -ETVLTSFLLALSSLFSIVNPVGSALMFAQITSDRSQAERAELSRRIGFYAALVMLAALWAGAPILNFFGVSLAALRIAGGLFVAAFAWTMLTAPEAREARKHAEVEAEPEAGENLAEVAFFPLTLPFTTGPGTIAVAIALGANRPSEPGELAGFF-LGASLAALAIAGVIRLAYGSADRVVTLIGSVRARVLGRLSAFLLLCVGTQITVSGVSDVL----
     84 UniRef50_B8ICA0        Multiple antibiotic resista...   138     1e-31  1  27.7%   1:220   4:229     IESALQSFLLALPALFSIINPLGGALIFAEVTGRRTHEERVLLARRIGIYAAAVMLVSLWLGATLLSFFGISLAALRIAGGLVVAAQAWRLlaRKAADAASAKTRDREVGVESGGLDEIAFFPLTLPFTTGPGTISVIIALAASRPEAGA-ARWGFLLGATLAVLVIAASVRIAYASADRVVKRIGHARARVLGRLSAFLLLCIGTQITLTGVSDVLEPL-
     85 UniRef50_Q3SRM8        Multiple antibiotic resista...   138     2e-31  1  27.8%   6:217   4:206     -----DYALTTFATLMVVVDPIGLAPVFLSITQGLPKAARRGIGWRASAIAAAILVATALGGTWLLARLGIGLPAFRISGGLLLFVVAFEMVLGVRPAREAQQATQAAE----EHARNIAAFPLAIPMIAGPGAITATLLLAGRAADQP-----VQLIALIAIIIAVAAICGVTFALAGRVAGALGHTGNVVLSRLLGVVLAALAVQFVIDGIREAF----
     86 UniRef50_Q2RH58        Multiple antibiotic resista...   137     2e-31  1  22.1%   4:220   1:208     ---MSVFFLHAVVSILAILNPIGNLPIFLSLVEGEATADQIATARRATLAAFGFLTLFVLLGNNILLFFGITLAAFRVAGSIILFSIGYKILQGRNI---HSRSLAPDIHEDIMARDDVAITPLATPILAGPGSITTVMLLVGS------EWRLRTILLTVAAIAVVTLGTYLIFRYATLITRHLGPMEMNIISRVMGLLLAVIAVQMGASGLLELFPGL-
     87 UniRef50_Q0W3L9        Putative multiple antibioti...   136     4e-31  1  22.8%   6:220  10:210     -----TLFIHALVGVFVIVNPFGNIPIFISLTSKLTPAERRTAIIKSLLIATAILLVFALIGQAVFTLLNVTLPSLRIAGGLLLLAIAFDMLMGRS---------PASKIDESDEREAVAVTPMATPLLAGPGAMSTVMILMNEAATND-----LQKLSIFLAILLAMGAAFLILINSELLYSVIKKDGSRVLTKIMGIVLATIAIEMMVNGLLKAFPVL-
     88 UniRef50_Q12Z49        UPF056-domain protein n=2 T...   136     5e-31  1  22.9%   2:219   1:208     -MDHVSYFINSFITLFVIVSPITGVITFITLTNGLSLREKNVIAKKSVTLAFIISMFFIFTGTIILDVLGISLDSLKVAGGLLLLTVAFDMMHAK----ISRQSITDKEINASYERDDIWIFPIAMPILAGPATITTAIILTETAE------VVQQKMLLILAAVITYSVAMVTFLFSRRIHKKMGYNGMLVLTRLFGLFLGAISVDMIASGVWGLYMS--
     89 UniRef50_B8ELV6        Multiple antibiotic resista...   136     6e-31  1  26.1%   1:218   1:209     MTKEWALFLSTFATLLAIINPFEALPIFLMLLEGKDLSEHRRVAARATLYATLLLFFFLIFGSLIMQLFGVPLSMVRIVGGIILVKIGFELFSPSPNGGSIIPDASSKTA-------NFAFVPLALPIMCGPGAIATV--LGMQSEIKEAPEHIGRFAATSLAILCAMFVTYLCLAYAGKLVDKLGPMGIDATTRIVGFFVSAMGVGLVFNGVLQGLH---
     90 UniRef50_B8GMF3        Multiple antibiotic resista...   136     6e-31  1  25.5%   4:211   1:199     ---MFETLLAAFVLLFIVVDPIGVAAIYAALVQGADRREQKRIARNGVLLATGILLTFMLLGNGLLAMLGISIPAFRVAGGVLLFILSLDMIFARQSG---LRATTLKEQREAVRSQDISVFPLAFPLIAGPGAMTTVLLMASSGHDALVLTGLMGVVLLVLALALIAL------WFAPVIVRGLGETGINVVNRMLGLILSALAVQFILD----------
     91 UniRef50_B4E5W5        MarC family integral membra...   136     7e-31  1  20.6%   4:221   1:201     ---MEYTFLSATVLLVLITDPLGNIPLFISAMRDVPRERRVKLILREVGIAFMILLFFMVVGDRFLRMMSLTDLSLRLGGGIVLFLIALRMIFPHPDGALGSDPRAGGE---------PFIVPLAIPALAGPSALATVMLLTSQAPGK--------MFEWVGALTVTMIVCAITLVLAERIQAWLGERTVAAFERLMGLVLVAISVEMLLAGIRAFVHQLQ
     92 UniRef50_Q0W501        Conserved integral membrane...   136     8e-31  1  23.1%   5:220   3:211     ----FELFVSAAISIFVMSDPFGNIPIFLSLTGGMNRPQRRRVITKASIAATVIIFIFAVVGQPAMNLLGISLNALSIAGGMLLLLIALDMLMSTGLHAKRTESTENTTH-EDEEADSIAITPMATPLIVGPGVMAATVVFMNRA------AGLMDQALVLSAVLIAMLGSWIVMVNSDLLYAILHRDGTRVLTKVMGIILAAIATEMMISGLLNAFPAL-
     93 UniRef50_C5CP73        Multiple antibiotic resista...   135     8e-31  1  24.1%   2:221   1:214     -MSTSMDLIKPLVTLVAIVNPLAIVPFFIHYTQGYSDAQRRHTVRMSAFSAFVVIAVSALIGLQLLAFFGISIASFQVGGGLLLLMSSLSMLNAKPAESKTNVEELRATEVKASMGASIAVVPLTIPLLTGPATISTVVIYADKTQHLWELGLLVGYGVV------VALATALAFSLAQPIARVLGKTGINIMTRLMGLILAALAVEVMADGLGKLFPILQ
     94 UniRef50_A6SZ91        Multiple antibiotic resista...   135     1e-30  1  29.9%   4:217   5:218     ---FFKAAILVPITMLPIINPFGNAPVFASLLGNVSRDVEKKLARQVALNCFFLLLGAMFIGSHVLMFFGISIPIVRISGGLLVAFTAWRLLNdgQDAIRTQVATAPMEAWSDEEFKVRSFYPISFPLTVGPGAIAASITLGASTPARLLDQVISLGSAAVGA-AMTAFVIWLCYNSANKMVKMLGRLGTMVMLRLSAFILLCIGVEIFWTGVVGLL----
     95 UniRef50_A5FZ91        Multiple antibiotic resista...   135     1e-30  1  23.7%   4:218   5:210     ---FIADFLYAAVALFVIIDPVGTAIIFAALTTHDDAAKRRTIAKRASAISFLVLLVFGLAGEKLLRLLGIGIPALQIAGGALLFLSAKDMV----TAKGELRASSEERSAASESTEDISVFPLAIPLIAGPGGMTTMVLLHAKAGGQPGAVLANALALAAMIAATL-----VSMLGARRLARLMGATGASVVGRVLGILVAALAAQFIIEGTQAALH---
     96 UniRef50_Q464W8        Multiple antibiotic resista...   135     1e-30  1  25.2%   5:218   6:209     ----IGFLIHVFTIIFVVVNPISGVVTFISLTSKMRDEEKNEIAKKSVILACVIALFFAIAGDIILNLFSISVDSLRIAGGILLFSIAFDMMHAK----ISKGRITEEEISHSQEREDIWIFPISLPLLTGPGTISTVIVLM------GGTGAIVQKIIILVSITLAFIICYYIFQFSRMIHKLIGYNGMLVFTRLMGLLLAALAVDLIVKGILNIYQ---
     97 UniRef50_Q0AE03        Multiple antibiotic resista...   134     1e-30  1  30.9%   1:217   1:204     MINPMDQYIQAIVALLAIANPLSAVPVFLQAVDGLDRTQRRKSALLAAISVFTILFVAAVAGNWMLDIFGISISAFRCGGGLVILLMGLTMLQGRTSSVQQ-------ESLTHNERRSKIFVPIAMPLVAGPGAITTVITIA------LAEPYWKNLSVALTAIVVLTMVLWVVLLLSQGVQGLLSPLGQKILLRFFGLILVAIGVQFILAGAYEFF----
     98 UniRef50_D0XZK3        Multiple antibiotic resista...   134     1e-30  1  24.7%   2:220   1:217     -MSIQYLALNFIVALFALINPIGNLPVFAAMTAGAKPKARRRIAVYIGVFIIGLLGIFYLSGLALLQVFGISLSAFRIAGGAILFLLGLDMARNDLNGGDEADELaaDHPSYARRLFERILVPFAIPILIGPGAISTVVIYASETRSMGMDAMAAGMIGICAAAAAVVAVLWAT----PFISRLLGRVGMTVTVRVLGLILCAMAVQFMIMGAADATHGF-
     99 UniRef50_Q01Z86        Multiple antibiotic resista...   134     2e-30  1  26.7%   3:219   9:222     --ELTKTTLLIVGALFPIVNPIGNTPIFLSLTHGLSSQGRTVLARMIAINGLILILASIFIGTHILAFFGISLPVVQVGGGMVVIATGWTLL--RQPNDDGSGDSGARDECHEADYKRQAFYPLTLPLTVGPGSISVAITVGANRP-EGAEWRWPLIGGMLLGSALIAVSIYLSYRFAERLAQTLGDSAMNVMIRLSSFILLCIGVQILWNGLSALLRT--
    100 UniRef50_B3EKF2        Multiple antibiotic resista...   134     2e-30  1  27.6%   1:221   1:210     MHELLSHTLVMVGGYFAIMNPLANTAIFTAVTAGMDDRGIKKTALSAVVTALCIVLCFILLGRIIFDFFGITLPALRVAGGIMVFFIGFDMMHGRTSAAHAPAGG----GASGTPGQNLGISPLGIPILAGPGTIAVSMSYSATGNG-------LDIAVNALVFSVMCLITYVFFLLGEKVEQKLGREGLKVITQIMGLILSVIGVQIGIEGIFGAISLFQ
    101 UniRef50_B0UBD2        Multiple antibiotic resista...   134     2e-30  1  26.4%   5:220  11:253     ----LQSFLLALPALFSIVNPLGAALIFAEVTGGRSHGERALLARRIGLYAAAVMLISLWMGAALLSFFGITLAALRIAGGLVVAAQAWRLLAAPEEREARKAAQAepEGVAGAGLDEIAFFPLTLPFTTGPGTISVAIALGASRPESGAARYGF-LLGASLAALVIALSVHLAYASADRVVARIGPARARVLGRLSAFLLLCVGTQITLTGVVDVLAPL-
    102 UniRef50_A5W9L0        Multiple antibiotic resista...   134     3e-30  1  21.0%   4:217   1:196     ---MLHELFSVYLKMLVLYSPFFVLSCFISLTRGHSSKERKQLAWKVAFAALVASVMLYLFGRAIFGIFGITADAFRIGAGSVLFISALGMAQGKPA------------VQADNVQQDVTIVPLTIPLTVGPGTIGALLVMGVSQPH------WDEKLLAIVSIALASFTVGLVLYLSHGIERILGDQGLQIVSRLMGLFVCALAAQIIFTGIKGYL----
    103 UniRef50_Q164H0        MarC family integral membra...   133     4e-30  1  26.9%   1:216   1:203     MIVDTAFLITAFVTMFVVIDPIGLAPLFVALTHGMSDEARRRIALRATLIAVIILLAFATFGEALLTFIGISMPAFRVAGGVLLFLTALDMLF-------ERRTKRREDRSEEDDSDDPSVFPLAIPLIAGPGSIASVILLMGQRPG------LEGAVMVLGATGLVMLIVLAFFLISGPVGRALGKTGITVVTRLLGMLLAALSVQFVLDGLAAF-----
    104 UniRef50_C6BVR8        Multiple antibiotic resista...   133     4e-30  1  22.7%   4:219   1:199     ---MLALFFQTYLKLFFVLTPFFAISAFLSLTQEMSPAERKKTAVKVTVAVIVSSVILYLYGRYIFDVFGITLDAFRIGAGAVLFLSALNMVNG-----------GGKKFDAGKDDDDIAVVPLAIPIVVGPGTIGALLVMGSGVQGYKD------MFLACCALVAAVLTVGILLFISSSLKRLLGKRGLNIMSRLTGLVVASIAAQIFFTGLRNFMLN--
    105 UniRef50_Q21G51        MCP methyltransferase, CheR...   133     5e-30  1  20.1%   5:218   1:202     ----MIDYLAVFITFFAVIDPIGTVPVFIAVTREYDQKTKRRIALLATIVAACVLLFFVVIGEIILKALSIPLSAFQISGGIVLFLFALNMIFGDSKP-------EEEIKFLEDDHKDTAIFPLAVPSIASPGAMLAAVLLTENA-----IFSLFEQVQTVVMMLLVLVVVYILMLLSGFITRFIGTSGASVVSRVMGLILSAIATTNILTGINEYYQ---
    106 UniRef50_A3JXR0        Multiple antibiotic resista...   132     6e-30  1  19.4%   1:216   1:204     MVLDWSALLREFITLFVVVDPIGTLPVFYFATARVPQELHWKFAVRAVLVAWVVLIAFLVAGQWLLEGLGLRFGSFQIAGGIILFLFALTMIFGES-------KAEHEIEEAAREHFSGAVFPLAMPSIASPGAMLAIVVLTDNHAH-----SVPDQLMTAGLLTIVLILTLLLLLLGAQLKRVLGSTGASVVSRVMGIILATVAVDAVLGGLDAV-----
    107 UniRef50_Q2FRJ2        Multiple antibiotic resista...   132     6e-30  1  26.0%   1:219   1:216     MVSDVGYLVGAIGTFFAILDPFGNLPFFIAYTNTLSAPVRRKTALVLSAFIFVAMAVFLFSGQMVLSFFHISLPAFQIAGGIILFGVALSMMSGTHTITMNRVISDTGKEMLLEKNESiiIVPLGIPLYVGPGSIAAAILFGSNAPTETAFLGGLLVILLIVIFITILNL------SSDYIGKVLGNQGIEILVRLMGLVLAAIAVQLTLDGITGAITT--
    108 UniRef50_A9HK24        Multiple antibiotic resista...   132     8e-30  1  27.7%   4:216  20:232     ---FSDTFLLAFPALFSIVNPIGASLIFTQVTAGRARAESLALARTVALYSAVLLIASIWIGSAILAFFGITIDSLRIAGGLVVAVRAWALLQAPEeaRKEQQALQGGRTVAVPRWTEMAFFPMTMPFTVGPGTISVAIALSAGRPASSGW--LVFYVALSLAAIVVAGTIWLAYAYAERLMALLGVTGARIVSRLAALILLCIGVQILSAGIKGL-----
    109 UniRef50_Q0FG46        Multiple antibiotic transpo...   132     1e-29  1  25.8%   4:216   1:200     ---MFELFVTAFVMLFLVIDPIGLLPIFISLTLGNN-KNRLKIGLRACSVALGILLLFGLLGENLLSFIGIGMPAFKISGGLLLFLTAVEMLF-------SKRGQRREEQTEMDVHDDPSVFPLATPLIAGPGSMATMILL-----LDSDVSGVTSTLVVLSAMISVVFLTFIFFSLGGPFERLLGKTGINVITRLMGMLLAALSVQFVVDGLNGL-----
    110 UniRef50_Q89AL9        UPF0056 membrane protein bb...   132     1e-29  1  26.5%   2:220   5:214     -MFDFSIYISFFFSLFALVNPIGMIPIFTSMTNHQSIVERNKTNLIANFSVAIILSISLIFGSFILNLFGISINSFRISGGILVMIIAISMINGNFINNINNQKNG---KLDKDIARNISIVPLAMPLIAGPGAISSTIVWSTHY------SSVENIFGCMVTIMLFSCFCWTLFKVSPIIVDILGRTGINIMTRIMGLLLMSLGIEFILAGLKASCSNY-
    111 UniRef50_A1SUP4        Multiple antibiotic resista...   131     1e-29  1  21.6%   4:216   2:196     ---DTTAYLHALTALFVIIDPIGAALIFNSLTGDCAKKHRTVMAVKAVLISGVTLILFGNYGEALFGHLGININSLRISGGLLLFYTAFNMV------------TKATGIMSASNSDDISVYPMSIPMISGPGTLTLSILLFSHT------TELSGKLAVSSAIISILALTLVCMLVSKYLKKIIGKTGDEILKRFFGIILAALAIQFIYDGIKNI-----
    112 UniRef50_C5BZ38        Multiple antibiotic resista...   131     1e-29  1  26.2%   4:217   6:203     ---DVTLFSTTFLTLFVIMDPPGTVPVFLALTSTMTAKQRARAALQAVYVAFGVIMAFTLFGQAILRFLHISVPALQASGG-----------LLLLLVALELLTGKAEEPQPSGRGVNVALVPLGTPLLAGPGAIVASMLAVQQGDG-----DVASWVAIIAAIVLVHVSLWIAMRFAGVIHRVLGEGGTTLVTRIAGLLLAAIAVQLIADAVRAFV----
    113 UniRef50_A5GJB9        Uncharacterized conserved m...   131     2e-29  1  21.4%   7:221   2:204     ------SLLHTAVGIFTISNPIGNLPIYLSFTDGNRRKDR-AIARSSAVTFLVSLMLATWLGNDLLGFFGISRPAFQVAGGLIVVLIGLSMLRSEPSKVHHDPASIERDQDSAVK----GIVPLGIPLLAGPGTLTVVIA-------DPNAASMGGKLGISGVVLLLTVVVYVIFEAGEMLSSKISASALQVLTKIMGLLLTSIAVQMIFTGLRAGFPVLK
    114 UniRef50_Q2SCP9        Multiple antibiotic transpo...   131     2e-29  1  24.2%   2:220   1:210     -MLEFHEYTKILIGLMAIVNPVNAVPIFVAFTSNVSGAERKKIGKSVVIAVGLILLISMLLGEYLLSFFGITINSFRVAGGILILLMAISMLHAKVSATVHTEEET---VEEEGHHHSVAIVPLAMPLLAGPGAISTVILYAHRGTDAAH------YALVGVAILILCLTLWLVFSMIPWFSSHLTKTRINIFTRIMGLILAAIAIEFIANGLKGLFPVL-
    115 UniRef50_A1TTZ1        Multiple antibiotic resista...   131     2e-29  1  29.6%   4:216   9:219     ---FGKSFLFVIAALLPIVNPAATAPIFLGLTEGASPTTRALLARRIARNMFWLLLGAMLVGSYVLEFFGISLPIVRVGGGMIVAATAWRLLTATQATVDSRTELA--ESFTPDMARRQAFYPLTFPVSCGPGSIAAAITVGVSLADARLSMSLARMGGGVLALLSVAVLLYFAFRYAQQLLKPLGEAGSVIFLRLSAFILLCLGVQIVWDGVYEL-----
    116 UniRef50_C9YF10        UPF0056 membrane protein bb...   130     3e-29  1  20.4%   4:219  19:214     ---MNYTFASATILLILITDPVGNIPIFANALKHVAPERRPKVILREILIAFTLLLTFMFVGESFLRVMNLSELSLQIGGGVILFLIALRMVFPPAATA------------ETEIKTEPLIVPLAIPAVAGPSALATVLLLVSQQPDRRMEW--------IGALCVTMLVSAVVLVSAERIQRIIGDRLVVAAERLMGLVLVSVAIEMMLRGIKTFVHQ--
    117 UniRef50_A6UWA4        Multiple antibiotic resista...   130     4e-29  1  24.4%  15:219  18:212     --------------IFIIMNPIGLVPLFYIWTSESEKTEKIELLRKSAIAVMLTLLTFALFGGSIFKFFGITLDSFKVAGGILMLKIAWDMLHAQVSKTRHNLK----DDEEPISLEDIAVVPMAIPLLAGPGTITTSIILMEHSITTYD------TLIIMFSIILATLISVVILYLSDNIARILRVSGIKAIVRIMGLILAAISIEIISSGVFGLIKS--
    118 UniRef50_Q2RRC7        Multiple antibiotic resista...   130     4e-29  1  24.8%   4:217   1:208     ---MIDSLLSQITTLLVLVDPLGLLAIFVGLTAGRPAAYRRQVAIKGTLLATFVLVAFAVAGGKFLHLLGIDISAFRIAGGLMLLVLAHEMIFAKRT-IRRNESAKAMDKEMGGETSDPSVFPLAIPLIAGPGAITAVLLFSRESDGTAIGLMW-----VIVAILAVTLPTLALLLTAGAVQRMLGETLTHTLDRLLGIILGALAVQFIISGAKEAL----
    119 UniRef50_B5JIG7        Putative uncharacterized pr...   129     5e-29  1  23.4%   2:215   1:204     -MGLLEYTLLAFVTLFVIVEPISIAPIFLAMTAGNDRSARTRTAKIACVTMVTVLLLFAVVGMSLLEFFGISVAAFQTSGGILLLLI----ALDMLQAKESSRKITQEESDAGTAKEDIAITPLAVPLLAGPGAITTCIVLANQAE------AWDQRMALYGVIIFICGLTFLILKLADKGAAWMNPLFMRVITRLAGLLLAALAVQFIFNGLRD------
    120 UniRef50_B6IU07        MarC integral membrane fami...   129     5e-29  1  22.2%   4:215   1:207     ---MTDLILATAVAFLVTIDPIGLGPVFAGLTAGMEHSVRRRMAVKGVLIGAGLLFVFALVGEGLLKALGIGVGAFRIAGGILLLLLAIEMVFARESGIRATPDERAEAQDKVMHDADISVFPLGIPLIAGPGAMTSVVLLMGRASG-----DLASQAVVLGVLAAVLALTLVVLLFAAEVSRFMGVTGINVVNRVLGILLAALACQFVIDGLIE------
    121 UniRef50_B1L4D5        Multiple antibiotic resista...   129     5e-29  1  25.1%   5:219   3:202     ----IEEVGISAIQIFAILNPISVIPIFLSLTEGRDEGEVRRIVGVVSVAIFIMMSIFSLAGELILKLMGISVRGLKIGGGAILMVLAVDMLQGMPRTKS-------------VEEEELAIVPLSTPLLVGPGTMTTILLLSNKYSGTYGY--LCSSLILTLASALVTVASYLILRNSGKLRKVLGVNGLRGLGRFMAIIVAATAADMISSGILDFIKS--
    122 UniRef50_C5BLR4        MarC family integral membra...   129     6e-29  1  23.4%   5:213   1:201     ----MEYFIVAFMTFFATIGPLDVAAVFAALTARYKPREARKMAVKGILISISILLLFALSGEWLLSQLGISLAALRAGGGILLLLIGIDMVFARTSGGTS---TTADEEEEAITREDISVFPLATPLIAGPGSMGASILLMANAEGHPWQQGAVLLALAAILLLTLVML-----LAAAQIQRILGVTGMHVITRVFGVLLTALAVQFIFDGV--------
    123 UniRef50_D1JAD6        Conserved hypothetical memb...   129     8e-29  1  25.5%   5:220   8:216     ----LTFSIGAIIAILVISNPISTSAIFIALTERMSRKQKQDTIKKSLTYSAGILILFALTGLLLFRIFGFTIGAFRIAGGVLLFTTAVGMLNPKTSQ-----------EEATDVPDNIALIPLSIPFTAGPGTIVTVVVLMSemHSTDLFTGIVCALGVFIGIATCLGVTYVMLAKSDLIDGALKEGGRRVVTTLMGLIVMAIAIQFFINGIKDILPDF-
    124 UniRef50_Q08WP7        Putative uncharacterized pr...   129     8e-29  1  26.0%  41:217   2:168     ----------------------------------------RRTALRACLVACGLLLFFAVFGGVIFQVFGVSLGAFRIAGGILLLITALDMLRARPTETRTSR----TEEQESAAKEDVALVPLAMPLLAGPGAIASAMVLMAKGGT------LLMTVPVLAAIVLTFVASYFILRASHLVQRALRQSGVAILERVMGLILAAIAVQFMADGAKDLL----
    125 UniRef50_D1B0T6        Multiple antibiotic resista...   129     1e-28  1  23.2%   1:220   1:211     MTEFFNLLLQHTITMMAIVDPLGVSAIMLSLLPQSTTKEHikIARKATLTIIVAFFVVLISGNFLLNLFSIEIDSLKVMGGIILLFTAIKMVQG----SMESKNQTEEEREEAIKNDEFSVIPLGVPITFGPGIFATIIILRGHSEG------FISIAALIMAYLIVALSVYLAFKNSIYIRKYLGITGQKIVSRLMGLIVGAIAVQFIVGGVSVLVKHY-
    126 UniRef50_A2BM88        Predicted transporter prote...   128     1e-28  1  23.8%   6:219  10:204     -----ETLVQSIVLLFIAIDPIGNAPLFYSLTARLDARLRVRIVKQSCIVATSILFVFALTGNTALSYFGLTLADFRIAGGIVLLIYGIAGILGWT---------EAEMIRHPEEVESIAIVPLATPLLAGPAAIATVLYVRAVHGLTY----------ALASVTVNTAITFLMLYHSQKLMNLLGKNGAIALSKIMAMLLAAIAVAMIRTGIQDILAT--
    127 UniRef50_C6E1T4        Multiple antibiotic resista...   128     1e-28  1  20.2%   1:218   1:200     METYSEFFFTVWIRFFFLLTPFFVLSTFLAMTPELSASERRATALRVTLAVLIACFVLYSFGNTLFSLFGITLDSFRIGAGSLLFLSAVHMVQGDDS------------APPSEKRGAISVVPLAIPVTVGPGTTGALLVMGAEVQHNWQ------VFVGLAALAAAVLCVGILLVCASFIEHIVGKKGITILSKLTGLFVAALAAQIVFTGVRNFLQ---
    128 UniRef50_B9NS57        Putative uncharacterized pr...   128     1e-28  1  23.7%   5:219   1:209     ----MNNLLEHFVTLWVVIDPIGTIPVFIAVTAGIAAGARRKTALLAALVSAGILLFFLIFGQLVIEALDIGLNSFQVAGGIILFLFALTMIFGESKQAVEQR-QAEEDADDQLHKTNPAIFPLAVPSLASPGAMLAIVVLTDN-----NRYSIADQSITALVMLAVIAIAFVLMLLAEPIIRLIGHSGAAIISRVMGMILASVAVNSVLSATIAIIKT--
    129 UniRef50_Q31LF6        Multiple antibiotic resista...   128     1e-28  1  25.0%   5:220   3:214     ----WPLVLNFAVALFAVTNPLGNLPIFISYVGKEKPSVQRLLALFLVLTVFISQLVFLLSGTAILRFFGISLAAFRIAGGIILLLIGINMIQGDRTKANQKLagIKSAFRRAETVYQSFFIPLGIPIFVGPASISTAVLYGNLANN------LATNLGLIGAVIAICIVSWLTLSVASWFERILGDLGLEITSRLLGLMLAAIGVQFILNGLGEATIGF-
    130 UniRef50_Q2SQZ5        Multiple antibiotic transpo...   128     2e-28  1  27.2%   8:220   3:196     -------IVSALTLLIVVMDPLGNIPLFLSILERVDVKRRKKVLFRELLIALAILLVFLFCGQYLLKIFSLSKESVGIAGAIVLFIIALRMIFP-----------AKREWLEDLPDGEPFIVPLAIPFVAGPSALATLILISTREPERMMDWSI--------VVLLAWSVTAVTLMSSTFLYKVLRKRGIIAIERLMGMLLIAVSVEMFLTGLQPILTKL-
    131 UniRef50_C6XRN8        Multiple antibiotic resista...   128     2e-28  1  24.4%   4:216   2:201     ---DWGSLYRDLITLFVVIDPIGTIPIFIAVTAGMAPENRPKVALIGVLIAAIVLYTFLILGQLVFEALGLALGSFQIAGGIILFLFALQMIFG--------PSKPEEELNQAKSISQSAVFPLAMPSIASPGAIMTVIILTDNHGH-----SVLEQTATAGLLLGVLVFTFVLLLLANPILKLIGTSGASVISRVMGMILSTVAVDAILNGFAVL-----
    132 UniRef50_UPI0001746B52 hypothetical protein VspiD_...   127     2e-28  1  25.7%   9:218   7:197     --------ISALVLLLIVLDPLGNVPVFSSLLRQVEPARRKRVILRECGIALVVLFLFLAFGGGFLKLVGLSQSSLGIAGSIILFMIALRMVF-----------ESTEKVFGGLPQGEPFIVPMAIPMLAGPSALATVILFTTREG--------ISTLGAVGAISIAMGVTCIVLLLGERIIRLVGERGLAAMERLMGLLLTAIAVEMFLRGVKEFMK---
    133 UniRef50_Q3SH12        Multiple antibiotic resista...   127     3e-28  1  22.7%  18:220  20:213     -----------------IVDPVGVIPIFLMATHGFTLTQSRAAARIAALTVLGVLTIFAFAGETLLTFFGIRLAAFSVAGGLLLLLLALSMVEAHVS----PQRQTQDEAVEAEEKDSVGVVPLGVPLLAGPGAITHVIVAAGALEGHTLQRGLLLLPVGLV-----ALSVWLAFRAAPVIAKRLGKTGIHVVTRLMGLIIAAISIEMIARGLGELFPGL-
    134 UniRef50_A5G1Y0        Multiple antibiotic resista...   127     3e-28  1  28.1%   4:220   2:216     ---DLAFAARFLGAFFAIMNPFVTLPIFLSMTADRTVAEQRSIALQIGTYSTVMCLVIAVAGNAIIGFFGISIDAFRVAGGLVLLGIAFSMLNGHPITAHERGDHEKSADSAADAAdgIAFYPLTFPLVVGPGTIATLIIYAGQARGVPE------YVAFGLITALLLAVLIVVLYFAASIGRLLSARMRVVMTRLMGMILAAIAVGMVTAGLKILLPGL-
    135 UniRef50_C1DWJ6        Putative membrane protein n...   127     4e-28  1  25.0%   2:221   1:211     -MDVLYLILKYTISIFAIVDPFGAIPLIISVLKNFSDKEREFIIKKASIYGCFILIFFLFLGNFFVGILGVSIADFQIAGGIILLLISINIIFGQPL----KEKISPEEIPLIKKLENIALIPVATPILAGPGAMVTAMTVASSQE------SLLNLLIVAISIVITFLISYFILKASKYIQKLLGEIFLDIVSRMMGIVIMALAVQFIVKGIknFFPILH
    136 UniRef50_A3YU86        Putative uncharacterized pr...   126     4e-28  1  24.7%   6:220   9:217     -----HFMVQFVTSMVALLNPLGDFALFLALTQGRSRAEQKSIGNQAAVAIGVIMLTSLWLGRAILGGIGISIGAFSIAGGIVLFGIGLGMLNSK-SGDSSKTESNQDNIDAGRMKTSPAVVPLAIPISAGPGVITALLVASHSNE-----AGIPGLLALSVASVVMAGMMAVVFWYAPALGRLMGPSGMQITTQIMGLIVTAIASQMVLNGLKSAAPMF-
    137 UniRef50_A8HQV8        Putative uncharacterized pr...   126     5e-28  1  27.1%   1:218   1:205     MLEDYDLFITQFVTLYALLEPIGHLSLFLALTGEHSKADRLRLAILSPLFAFAVLSFFALAGQTLLNAMNVSILSFQIAGGIILFSFSLSMIFG--------EAKKPSGVPEEKNLISQAIYPLATPTIAGPGAILSVVLLADNNRG-----SLIAQSMTVLAVASMMLLLMGAFLAGDIITRLIGSGGTNLVRRVMGILIAALSVDLVLSALAKWLH---
    138 UniRef50_B2TBL8        Multiple antibiotic resista...   126     5e-28  1  25.9%   2:217   3:214     -ESLISDILFGFTGLISIINPIGIAFVFLDRTASLTTEERTALARKIAINVMCVLLVAFFIGTPILHFFGISMQALRIGGGLAVAVGGWQMLNAPDT---QPAEKPAVKRVDADNAMSKAFFPFTIPLTTGPGSIATAVALTANRTHKLSEFVISSIASVVISVT-VAVTVYLVYSRAVVFAKYLGVEGTKVAMRVSSFLLLCIGVQIMLTGFSEFL----
    139 UniRef50_A1ANN4        Multiple antibiotic resista...   126     6e-28  1  19.8%   1:217   1:199     MQIYGSFFFGIWIKFFFLLTPFFVLSTFLSMTQRYEARERRKLALRVTVAVLVACFTLYFFGNTLFSLFGITLDSFRIGAGALLFLSAVQLVYGD------------DKAPPGGEREVISVVPLAIPITVGPGTTGALLVMGAEIQQSWE------ILVGCAALATAVLCIGLLLFCAASIEHLIGKRGIIILSKITGLFVAALAAQIVFTGIRNFM----
    140 UniRef50_B5EQ08        Multiple antibiotic resista...   126     7e-28  1  19.4%   5:220  20:223     ----IEIFIQTLVTLLVLMDPIGIVPIFVSLTREQSTDQQKTTAKYISIVVALVLIISTLFGNDILRYFYIGIAEFNVSGGLLLLLMSIQMLTTDNISTTFGQGQASAYH------GGRLVTPLGIPFLAGPGAIGTVIIYGQHAHT------ILSYGLILIDVLIASFAAYIAMHNAHHISRFFGEIGIEIITKVAGLILGAIAVRFICQGLIRLLPGL-
    141 UniRef50_A9NB13        Membrane protein, MarC fami...   126     7e-28  1  25.6%   7:217   2:192     ------TLYTIAITLILVMDPLGNIPVFLAILKQYDARTQVRIILRESIIAFFILALFVFFGRYILHGLHITTPALSIAGGVILFIIAIRMIFP------------PDQKPAKEDFEEPLIVPLAIPLTAGPSAMAMVLLFVTRDPHHLW--------LIFLGVFIASLIFTLIMLWAPYLIKILGKRGLTAIERLMGMILTTIAVQMFLAGIAEYL----
    142 UniRef50_A3CST1        Multiple antibiotic resista...   125     1e-27  1  27.2%   4:220  10:206     ---FVGLTLVAVASITAVMNPASTTAVFTALTEGMTPDERRQVILTTVRISFIVLAFFALTGQLVFSIFNITVPAFQIAGGILLVTVATGML------------GSRGESYQAGDLENIAIVPLAFPLSCGPGTITAVILLTS--------AGASSLIAVFLGIAVALVISYVGMLYGPRIFAFIGEGGLRVVPKLMAVIVLAIAIQFIISGIAEAMPQL-
    143 UniRef50_A8UZ22        Multiple antibiotic resista...   125     1e-27  1  17.9%   3:220   5:213     --DYLRTLLQFTIGLITILNPIAAAAIMVSltPPVSKRELVSISKKTTLTILTASLLSTFLGDLIFKLFDINIHSIKVIGGIILLLFSINMIKGKIFEASH----TPEEHEEAKEKDDISIIPLGIPILFGPGTFTTLVIFKTSTHN------WIDLFILITAIFISSVVVFLVFKNAVLLDKFLGITGVKITTRIMGLIVGAIASQFIVSGVKSLWDMY-
    144 UniRef50_A4BBV6        Putative uncharacterized pr...   125     1e-27  1  22.4%   1:219   1:208     MVMNTTFFFNALTSYFVVIDPIGCALIFYSLTLGQSTRQKAKTILKSMAIALGIILSFAIAGERLLTALGISMDALRVAGGILLFNTAFRMITKVPEDQSL-----HHESPHDVRIGHITVYPLAIPLMAGPGTLTLTVLLMANGEQTVDQVMVIVAAVIVLLVTVLLS------VLSGKLRKVLGQTGDEIIQRLLGVLLAALAIQFVANGVNGLFLS--
    145 UniRef50_C4XI48        MarC family integral membra...   124     2e-27  1  26.0%   7:221   4:206     ------TFQHYLLGLFAVANNIPALPLFMNLCRGAQTPVQHRLCGVATASSLATMAISLFIGAAVLDFFGISIAAFRIAGGLLLVSSGLSML------KSSCDEADGLPPVSVSRMIPMAVVPIAIPLTTGAGTISTIVLFAESAHT------MAGLLRIGGAICVMSVVNYLAFYYSPAIVRFLGRTGMDIFTKIFGLITLALGIQFIITGLTAAFPVLH
    146 UniRef50_D1RJ36        MarC family integral membra...   124     3e-27  1  26.1%   1:218   1:221     MMVLIQAIFFSFAALFPIVNPVGASIVFLTLVKGSSRQQINALAIKISIYTVVMLLLVLVVGSLILSIFGITVPIVLISGGLLLTQVGWQMlhDESTGLSSSASQGKKISQLKSIEDPRAFYPLTLPVTAGPTCIAITIALGAHGAQNVWESKFLAMLGYSIGIILIGLSVFFCYRYSYYIFDKLKDAGKNVVMSLAAFLNICIGLQIIWRGIEMLIP---
    147 UniRef50_C7R1Q1        Multiple antibiotic resista...   124     3e-27  1  25.1%   4:218   6:205     ---DIRLLIEVYVTLFVIMDPPGTVPIFLGLTGSMTAKQRAGAARTAIAVAAGVILAFAAFGQQLLTYMHISLPALQASGGL---------LLLLIAMQLLTGKMEEEADSPSNKNVNVALVPLGTPLLAGPGAIVASMLFVQRADASADW------FALAVGFAAICLTLWVSMRFAGVIHRLLGESGTILVTRIAGLLLAAIAVQLIADAVIAFVR---
    148 UniRef50_Q89AB7        UPF0056 membrane protein bb...   123     4e-27  1  21.1%   5:217   1:197     ----MKEIISVTILLILIMDPLGNLPIFMSILKHLEPQRRKKILIREMMIALLIMLLFLFAGEKILIFLNLRAETVSVSGGIILFLIAIKMIFPTYESKKKSGNIIKRE--------EPFLVPLAIPLVAGPSLLATLMLLSHQYPKK--------ILYLIGSLLIAWMITVVILLLSDIFLRLFGSKGVNALERLMGLILIMLSTQMFLDGIKSWF----
    149 UniRef50_B5HXX6        Integral membrane protein n...   123     4e-27  1  24.8%   2:219   1:200     -MFDVAVFGSLFLTLFVIMDPPGITPIFLALTAGRPGKVQKRMAFQAVCVAGGVIAVFGVLGHQILDYLHVSVPALMIA------------GGLLLLLIALDLLTGKTDEPKQTKDVNVALVPLGMPLLAGPGAIVSVILAVQKAH------SVATQVSVWTAILAIHVVLWLVMRYSLLIIRVIKDGGVVLVTRLAGMMLSAIAVQQIINGITQVIQG--
    150 UniRef50_B9M3N7        Multiple antibiotic resista...   123     5e-27  1  24.9%   7:219   2:195     ------TFYAAVILLLLVMDPLGGIPFFISALKNVPEHRKKKVILRELLIALALMILFMFQGTKILKMLSISGPSLTIAGGIILLLIAIKMIFP-----------SKDEFMENVVGNEPLIVPLAIPYVSGPSALITVTLIMSREPHRWKEW--------LLALLFAWVVTGSILIMCTELERLLGERGVIAIERLMGMILTTIAVEMTLNGIVAFLAQ--
    151 UniRef50_C3X219        Predicted protein n=2 Tax=O...   123     5e-27  1  19.4%   5:220   3:205     ----WGFLIKKTLTLLALVDPLMAIPLFICATAGLDTGFKDKYSRQLGITVALSLLIGGLFGLHLLDFMGVSLASIQIGGGAIMFIVSLAMVIAKEETIKYTPRETEEAAS------GPSIVPLGIPLLAGPAALSYVMATSQITQAE-------DLLSVILPPVVVGAATWLCFRFVGRGGRILTPSAIKVIERLAGFLLTAISVEMMATGFRHVFPGL-
    152 UniRef50_Q4FNW7        MarC family protein n=2 Tax...   122     7e-27  1  24.2%   4:218   1:202     ---MLEIFIQTFFLYFIVIDPLGNTPLFLAVTQNMSSQQRVKTALSATIIASIILLFFAFLGSTLLNYLNISFPAFTIGGGIILLIISMEMLFDKRQQRK--------EDDIDFNSENVSVFPLATPIIAGPAAITSVIVSVSDMGSN-----FTNQSVGMIALASVLLLTFIFFFTASKFSQIINKKVISVISRVIAIILVGLSVQYILDGIKTFLA---
    153 UniRef50_Q3JBV2        Multiple antibiotic resista...   122     7e-27  1  22.3%   5:219  11:257     ----WELLGNFFAALVGILNPVGKIAVWSELAGDLPPPVRFRLALWNCLIAAGLLLLFLWQGQSILSFFGIQLPAFKVGGGALLFITAVSLFEGKVKENFHLPQEGKSGPNPPSMPQSptIVPMAVPLLAGPGTLTIAILFGLRAEGRGEFLQLSGVLLLSLFFVLGLLSV------GPWLERRVGKPLLSALMRIFALLLAGIAAQLILEGLEPVISG--
    154 UniRef50_B8D4C1        Multiple antibiotic resista...   122     8e-27  1  21.8%   2:217   1:197     -MDYLIILLSYFTQLIAIMNPFSAIPTFMSLTEGLERRRRLEIVKKAYFAGLILVILFTLVGRYILEAFNISIASLRVGGGIILMTIALDMLGDEVRTKRM-------------HPGDIAVVPIATPLIIGPGTITTILLLTSSLQET------TGMVVVLIAGVIACSVTFLILALSDILTRLLSMSTVRAIGRFMALIISGVAVEMIVQGLYSYY----
    155 UniRef50_A7BE02        Putative uncharacterized pr...   122     1e-26  1  30.1%   1:216   1:203     MMTVLAGMSAAILALAPITNPIGGLAAFAGLTAGNAAAAVRSQAWKTGIYVFAILTVFAVSGSLIMRFFGFDLPSLQIAGGLVVSHSGFSML-------ENKRRATHEETQHATSKPDVSFSPMALPLIAGPGSIGVVIALAAR------NTAIGFHVGIVLGIAVTAAVIALLLRYGTPWIDKLGATGVGAIVRIMGFLILVIGVELIIHGVRAL-----
    156 UniRef50_A3DKT0        Multiple antibiotic resista...   121     1e-26  1  25.3%   4:220   1:198     ---MFDLLFAYYIQLLAIMNPFSALPTFLSLTDHLDEIERKDIVRKAFITSIILVILFSLIGNYILLAFGISIASLRIGGGILLLVIALDMLGGMPRTKQ-------------IEYSDIAVVPLATPMVIGPGTITTILLLTSREPG------FLNIFLVLIASILAATTTFIMLRYSTKLVSILRVSVIRAIGRFMSLIIASVAVEMIALGIISFYHTY-
    157 UniRef50_B0U0F2        Multiple antibiotic resista...   121     3e-26  1  27.2%   5:217   7:207     ----IAVILKFIISLFAIINPFSLAGIYLDTVKQSDQKEKNTIVFTMILAFLAILSLMVWFGNNILSIFGINQDAFRAGGGVIVLFFGLRILGVLAQPVS-------DTTVKIVSARDLAVVPLAIPLLAGPGTIATVITDSHEY-----FATIESKVIANLCLLFVAIVLWLFFRYLPKISAFLGEHTIDVISKIMGLMLVAISVEMIFDGIKGFF----
    158 UniRef50_A8YHS2        Genome sequencing data, con...   120     4e-26  1  20.9%   5:195   3:192     ----WSFLRNFAITLFALLNPLGMLPIFISYTARERKEVQRLVALFVSLTVLCLLLIFMFIGTAMLKFFGVTLDSFRLAGGVLLLIIGINIVNGSGAGTKElnEQGGDYLSEAKSVYRQIVIPMAMPLLVGPGVIANVILYASEAESKLGRGT---SIELILMTILVSFLVFLILAAGKWLQRLLGDIGLSITQR--------------------------
    159 UniRef50_A1VE68        Multiple antibiotic resista...   120     4e-26  1  19.9%   5:220  23:222     ----MQDAFEVALPLFLIMDPVGNAAASLAILREHTPSRQRAIIRRELVFALAIVLLFHFLGDALLGLLDIEQSTLRLSGGIILFIIAMKMVFP-----------PAQENDPEAVTRDPFIVPIAVPLIAGPSLLAAVMVYARQAQ-----AGMMGQASVLGGVLMAWGATALIMAFTPDLARILGPRAMRAMERLMGLILILMAVQMLENGIRIFVQSL-
    160 UniRef50_D1N302        Multiple antibiotic resista...   120     4e-26  1  22.7%   2:217   1:201     -MMDVNMFIGMVVQFFFLLTPFFVLSLFVSLTSGMELPRQRKLAVRTTLAVMTIVLIIYLLGDRIFGYLGISLDAFRIGAGLVLLLSGIEVVRSSGTPSGTRQC---------DDDGDIAVVPLAIPYTVGPGTIGTLLTMGASADSARLRVTQ------IAGIVIAVLIMGLLLYFSAALERLLKKKGLNILSKLTGLFLAALASQLIFTGIRNIM----
    161 UniRef50_A4X2W3        Multiple antibiotic resista...   119     5e-26  1  23.5%   4:220   2:200     ---DIKLFGEVFVTLLVIVDPPGMMPIFLALTGPLSARDRHRAAWQAVALALGVIAIFAVAGSTLLDYLHVDLPALQAA------------GGLLLVLVALELLTGKADDPSQQATSNIALVPLGTPLLAGPGAIVATMLFMQQADGAADITAIAGAIIA------VLLAVWVVLRFSGGIVKILRPGGIEVLTRIAGLLLAAIAVQLIADAVAAFVTQY-
    162 UniRef50_C6QAI6        Multiple antibiotic resista...   119     6e-26  1  22.6%   4:215   1:204     ---MLETALKSLTTFFATIGPVEAAVLFATLTPKMPRAERQAIAIRATLIASAILAFFTVLGGPILAQLGVSVAALQTAGGIILLMIAIDMIFARPGGAI---KLTPPEGAEAQTREDVAVFPLATPLLAGPGAMSAGILLTANASDEP-----FGLAIVVASLACVMIATLALLLLAQELNRVMGITAQRVLIRVFGILLAALAVQALFNGIKD------
    163 UniRef50_Q8K9B4        UPF0056 membrane protein BU...   119     7e-26  1  19.1%   5:219   1:196     ----MNEIISTTILLILIMDPLGNLPIFMTILKKLDAKRRRIVVIREMIIALIVMLIFLFVGEKILTILNLKTETVSISGGIILFLIAIKMIFPSDEGNNGTSSE-----------EEPFLVPLAIPLVAGPSLLATLMLLSHQYLHHMPY--------LVGSLLIAWFFTIIILLLSGLFLKLFGDKGVNALERLMGLILIMLSTQMFLDGIKAWFKN--
    164 UniRef50_D1N0K9        Multiple antibiotic resista...   119     1e-25  1  20.5%   5:219   1:199     ----MDTFSSMLILFFLVMNPLGNLPVFIAELDRQPPERYRFIVLRECLIALAILLLFVFCGGEILKALRITQASLELAGGIILFMIAIKLVFGSASGSGEKKSAPESE---------PFIVPLAIPLFAGPAAMSTAILVGGR-------GGFMHTLEAAGALAAAWAICTAILLSGRYAGKFLGAKALSALESLMGLLLTTMAVEMIIAGIKYAFLS--
    165 UniRef50_D1JAE0        Conserved hypothetical memb...   119     1e-25  1  19.4%   7:217  10:200     ------LLAKSFIMLFVVMDPPGNIPIFMALTKGMSGGERKKELNHAVVVATILLLLFAFLGTMILYVLGITPDSFMIAGGI-----------LLLLISFDLLRGEHKYGTSGDSGAGVGAVPLGTPLLAGPGAITAVMVLMQEEN---------GVFIALFAIFTAIIATRFLLGQAERIYSIIGKVGSEVLSRVIGILVAAIAIEFIAKGIAGMF----
    166 UniRef50_A5EYD2        MarC family membrane protei...   118     1e-25  1  22.4%   7:211   2:191     ------SLTAAILTLFLIINPLGNVPVFLSILKNLSPKRQRIVLLRELCIAYAIMVVFLFGGSSILHGLNISREAVSISGAIVLFIIALRMIFPLRSGSVMGADDTEGE-------EEPLIVPIAIPFVAGPSLLATLIMMVESDPSLTTRW--------FFAMTISWFISLLIFLCAPFFFKILRKRGLKAVERLMGMILISISVQMMLN----------
    167 UniRef50_A3DL90        Multiple antibiotic resista...   118     1e-25  1  22.1%   1:217   1:194     MEIDVYQLVSAILMLFVVLDAPGNAPLFYFFTKDMEPWKRIYTIRKSIIVAAFILLLFGLFGDYILLYFDITVNDFRIAGGIILFIYAVLGILGHTTA-------------EEVSGEEIAVVPLATPLLAGPGSITVVIYL----------KYSMGLLLTMLSIAINMIIAWILLENGGKLLQLLGKQGSTVLSKILAILLAAYSVAMIREGIISLI----
    168 UniRef50_A6FM96        Multiple antibiotic resista...   118     1e-25  1  18.7%   1:214   1:202     MEKSLAHIMEEFAMLFAVVDPIGTIPVFLAIVISLPEEKRSSVAFKAVLIAGSLLLFFIAFGQMFLEAIGVSLSSFQLAGSLVLLLFGLNMIFGEARQDSEIGLAEKSDV-------ELAVYPLAIPSIASPGALLAVVLLTDNRTTP-----ILEQVITTGLVLVILMMTLACLLLATRVHKIIGNAGSSIISRVMGLIISALAVETGLDALS-------
    169 UniRef50_B1Y4J7        Multiple antibiotic resista...   117     2e-25  1  20.3%  23:219  20:198     ----------------------GSIPIFISVLKGVAPERRTRVALREALIAFSVLAVFMVSGQHFLTLMRLSERSLEVAGG----------VILIIIAIRMIFSGGSEIYSQDGEPREPFIFPLAVPLLAGPSAMATVLLLASRQPDR--------LLDWAGALTAAMAICATVLLLAERIRKLLGDSMVSAIEKLMGLVLTAVAVEMILAGLKRYFLN--
    170 UniRef50_Q31NH4        Multiple antibiotic resista...   117     3e-25  1  22.0%  11:219   9:216     ----------FATTLFAMLNPLGMLPVFISYTESERRQVQRWAALFISLTVFALLILFLLTGSTLLRFFGISLSSFRIAGGILLLLLGINLTIDNTAKQTRAIVKHEQESsaAESVYKKIVIPLAVPLLVGPGAIANVILHGTLAETEQQYGLLAEFALI---IALISLLTFIIFQSGRWFQKVIGDVGLSILTRILGLLVAAIGIQFLVAGVADVAAT--
    171 UniRef50_A1SV44        Multiple antibiotic resista...   117     3e-25  1  27.4%   4:215   1:204     ---MIETAGLALATFFATIGPLDVAAVFAALTANQTDQQKRTVAIRGTLIGTAILVAFALVGELLLSSLGISLAALRAAGGILLLLIGIDMVFARSSGGTS---TTDDEEKEAISKTDISVFPLATPLIAGPGAMGSAILLMANQHG-----DLTGQVIIIFSLLAILFLTFISLLLASKLQNLLGITGMHVITRVMGVLLTALAVQFIFDGIKQ------
    172 UniRef50_A2A0C4        Membrane protein, putative ...   117     4e-25  1  22.1%   5:221   1:204     ----MSELINSFLFLVAVLDPIGSVPVYLEATKDFDKKHKKKIAVRASFIAFMILLAFIVIGQFFLEGMSITLDAFRISGGLILFLFSLTMIFG--------ESKPESEKQLITDYKHVTIFPIAIPSIASPGAIMSVVILTDNH-----IYTIEQQIVTTLLVALVVFLTALILLAAVAVQKRIGDYGIIIISKVMGLILASYAVQNILSGLKNFFMSVK
    173 UniRef50_Q6MDE2        Putative uncharacterized pr...   116     4e-25  1  20.8%   8:219   3:194     -------IFNIALVLFFIMDPIGNISSYQTMVKELDRRHQSKIIFREMLIALVAMIFFNYIGEFIFDFLDLSETTVRLSSGIILFLIAIKILF-----------TANDSPRANLPQGEPFIFPLAIPLIAGPGLMATIMLYAHLEPYQS---------IMLASILIAWTLSVIILYFSKKIKSFLGESGLMASERMIGMVLVLIAVQRFLEGILLFWTT--
    174 UniRef50_A8ZZM6        Multiple antibiotic resista...   116     5e-25  1  21.0%   4:217   1:196     ---MTHLFLSLWIKLFFVFTPFFGLSMFLSLTEGYDEPRRRRVALTVSLAVAVLCLLLFFGGRQIFSLFGITLDAFRIGAGALLFLSGVGLVQGKPVNAG------------VASGSELAVVPLAMPIIVGPATIGILMVMGAELEGVRE------KMAGCMALLAAVACITVVLLMGSFIYRRLGAMGIGILSRLTGLVLAALSAQMIMTGIQAFL----
    175 UniRef50_Q5UEW8        Membrane protein, putative ...   116     6e-25  1  21.1%   4:216   1:204     ---MVTELVSLALIYFAVIDPIGTIPIFLSITERFDYKQKQRVALRGCAIAFFVLVFFGFFGDLILSHLKISSATFNIAGGAILFLISMEMVNGRRQARKSQAVEKNR--VSAEELIRISSSPLGVPLLAGPGAITSIMVFG-------DFTSLDKLVINLSSIFIALAASALLLYLAAWGSKFINLTISTVMSRLVGILLAAIAIQIILNGLNKL-----
    176 UniRef50_B1ZVN7        Multiple antibiotic resista...   116     7e-25  1  23.4%   1:214   1:192     MREFAGQFLQAFIPLFVAIDPIGLAAIFLALGTGVPLEQRRRIARQAAWTGGGVALLFLLLGQTIFGALGITASDFQIAGGLILFIIAARDIM------------HSAAEAPAKLADDFGVVPLGMPLIAGPASITTLILLAQT----------VGVWISLAALAVNLVLIVLAFAYSDKLGRLIGATGMRAISKIISLLLAAIAVNMIRQGVA-------
    177 UniRef50_B2KBR5        Multiple antibiotic resista...   116     7e-25  1  21.5%   5:218   1:194     ----MEFIFSAVFTLLMVMDPFGNMPIFITALRKVSPERRRFILIRELCIALLIMLAFVFLGRQFLGMMGIKEYSLSIAGGLMLFIISLKLVFG-----------SSEDPGANPKDEEPFVVPLAIPLVAGPGSLSTIMILSAQSPSKS---------IIWMAVLIASALNLIILLFSFPISNLLGRRGLLALERLTGMLLVLLSVNMVMSGVADFMA---
    178 UniRef50_D1R807        Putative uncharacterized pr...   116     7e-25  1  21.3%   6:221   4:199     -----QSIFSIALTLFLVTNPVGNAPAIIALIKDFDFSRQKAIMLREATFSLLLALFFQYFGEVFLNTLHIDRYTVSLCGGTLLFLISLSMIFPL-----------HHEETVKATKHEPFFVPIATPILSGPGLLAMIMLLSAQVSSN---------FAMSLAILLAWVGVFFVLLIAPYLNRVLGKRGLLALEQLMGLVLSIISTDMLVKGVEQFILSIR
    179 UniRef50_A8A8R0        Multiple antibiotic resista...   116     7e-25  1  21.9%   4:218   2:193     ---DLNAVINAFISMLIIIDPFTNAPIFYQLTSSFEPKRRKRIIVRSATVSTIILLVFALFGDLIVRPFGMTLEDIKVATGLILLIYAIQALLGKS-------------EAEMIDPESVAIVPMAIPMLAGPGAISLVLYYRSVLEPYE----------LALVVVGVMLVSLPILLLGGYLDKLLGKNGTLALNRILAILMAGLGIAMVREGLLTFIR---
    180 UniRef50_B1YA24        Multiple antibiotic resista...   115     9e-25  1  23.0%   3:215   6:196     --SDLMELLTAVVALYVIVDPLGNIPLFAALTAGLSEAQRSRVLLLSVLVASAVLVLFAVFGVEIFGYFGVELGDFMIASGLILISFSLH------------QLIRPYEQRPATDGLEVAVVPLAVPYLAGPASISYVLLMSKH----------MGVAPTLLAVAAVSLLTFATLRASGFIMRALGVLGIRVVEKIMLILSVAIGVSLVRRGLEA------
    181 UniRef50_C2BT16        MarC family multiple antibi...   115     1e-24  1  21.5%   5:218  13:210     ----LGLFISTFTTLFVIIDPFGNLPVFMSLTKDLPKKQRQTVALQANLLAIVILFVFGFFGFQLFGLLGISPAALQISGG-----------LLLLIVALQLLTGAEGTVGEEGGSLNIAAVPLGTPLLAGPGSIVALMVAMGNAGHHP-----LSVIAVASGAFAVMFASWLAMHFATPIIHFLGNSGVAVMTRLAGMLLAAIAVELMISGVISVVQ---
    182 UniRef50_A5FPP7        Multiple antibiotic resista...   115     1e-24  1  22.9%   1:214   1:191     MSDFWNNILLTFVPLFIVVDAVGNLPFVISITDQSTAEERKKVVNLAVITASLLGLLFLFMGKLVLDLMGISVGAFAIAGGLILLLFAIRYM-------------TSGHMVEVIKEEMVAVVPIGTPLTMGPATITTLILLVNQFP----------LYIVLISFALNMLATWLIFKSSQWFVHYMGRGGLKAMSRIFSLFLAAIAISMIIKGLR-------
    183 UniRef50_D1R808        Putative uncharacterized pr...   115     1e-24  1  19.2%   7:220   5:198     ------SLFSITLVLFLIMDPLGNIGSFREMLKRIDPKKQKIIIMREMLIALFTMLVFNFLGEVIFEYLQVTETTVQISSGIILFLAALKILFP-----------SKDSPRSNLPQEEPFIIPLAIPLVAGPSLLATIMLYAHMETSVP---------LMLGSIFIAWGLASIILLFSNRLYTVLGNNGLVAFEKLMGMVLILLAIQRFLEGVENFVKTL-
    184 UniRef50_Q4LEJ1        Integral membrane protein o...   114     2e-24  1  21.6%   6:218   7:195     -----DELIRASVSLFIVMDPIGLVPLIASLTSKLSIEQSRRVVRSTIYTASALLLAFAIAGHYILEAFGISLSSFRIAGG--------------LLLLLLSFELLLKGWELKGNEISIGAVPLAFPLLVGPGAITTILISLDRY----------GILVTMLSVAIVLALTMLTFSFMNTLNRLLGNLGSLIVSRVMAILIAGIAIEFILSGVEEFIA---
    185 UniRef50_A1U7B4        Multiple antibiotic resista...   114     3e-24  1  24.3%   2:219   3:206     -ETFFSTYLSSTIRFLFLLAPFFVVTMFLALTRGLSMAEKTSIIRRACVSAFILGVILFFAGPLLFNAIGITLNSFRIGAGSLLFLTAISLVN--------SGTRNHATGLPEEDRDDIAVVPLAIPVMIGPATIGAIMVYGAELKAVPEVAGGLLGLVSGLMILA------GLLRLSGYLEKALGKTGLNIMSKISGLILSAMAAEIVLTGIAGFIAS--
    186 UniRef50_B9KCI9        Integral membrane protein, ...   113     4e-24  1  20.1%   1:219   5:210     IESEIYIILLASVAIIAVLNPFGNLPQFIAMTEGLDADTRKKLFRNIIYTAFCIVLVFLLSGPFIMKyfKIDINDLRVAGGLILIIMSTKNLLFTPSSSQFQHYQG----LSHKELLKKSIVPMAFPMLVGPGTLSTVVVISEDQN----------LAIAIASVLLTFAFIFALFHFSATIEKVIGKLVLYVFSRIALVFIMAMGVKMIAIGVQTYIQS--
    187 UniRef50_B5YIN6        Putative uncharacterized pr...   113     5e-24  1  19.0%   2:217   1:193     -MEILNTFLLTFIPLFVAIDAPGILPLYISLVEGVPDKERKHIARQSVITAFLVGTLFLFLGNFIFSLLGIKLEDFMIAGGILLLILSISDIL-------------RVKEKELTISDTLGVVPIGTPLLAGPATLTTLIILAGNY----------GYPIVIFSLSLNLLIAWVMLEKAEFVIKVMGIHGIKAFAKVMALLLSAIAVSLIKKGLTKIL----
    188 UniRef50_A6VX13        Multiple antibiotic resista...   112     8e-24  1  18.5%   7:217   6:196     ------SILSATLLFLFVIDPFGNIPILLSVMKGVPQKRQYQIVVRDGLIGLVILVCFLFFGAEFLALLHLETESISIAGGVVLFVIALKMIFPSPYTK------------DAGPVMEPFIVPISIPMLAGPSTLATLLVMVKSYPNDQQN--------LLISVGAAWAISVAILAMAPLLNRILREKGLAALERLMGMLLLMMSVQMLVNGVRSLF----
    189 UniRef50_B7VQK4        Multiple antibiotic resista...   112     9e-24  1  35.0%   1:217   7:213     LETLFTYMTLTVLGLLPIMNPPAAATVLLGLSKGRDKSYIVSQAKTTGVYLFIALCITFFIGASVLELFSISIPSLRLGGGIIIVAIGFNMLFPRPDNGAAPSGQ-----------DSIALVPLTIPSLCGPGSMAMIISLAAQIATYENHTSMTsyGGVVAGLALVALIATFTLTMAYPLLKALGQNGINAFTRIMGFLLICMGVQFFTLGIQEIV----
    190 UniRef50_A1S0Q7        Multiple antibiotic resista...   111     2e-23  1  21.6%   9:216  13:198     --------LFVAVQLYAVLNPVSVIPTFVNLTEGLDSREKVHAVRKASMIVFSLMVVFSLIGDPLLRLLNVSIASLRLGGGVLLMVIAVDMLSGMSRTKG------------LESGDEALVVPIATPLLVGPGTITTLIVLSAS----------EGLPVTLLGALLATLLVYATLAFGESLLELLGRNFVRSLGRFMAIIIAGISAEMIHRALLEW-----
    191 UniRef50_B2UQV9        Multiple antibiotic resista...   111     2e-23  1  19.3%   5:216   1:198     ----MQDFLSTVILLFIVIDPVGLAPMIQGMLKKYSPAQQKAILTRELVFALSLLLLFFFSGKFLLNLLGLEPSTLSISGGILLFLVALGMVFPAKDMLSSSGR--------ADGKDEPFIVPIAMPLMAGPSSLSIIMLHASQTPDS------ISQMTYAGAIVTAWFLSGMVLFIAQKFLRLLGEKGTIALERMMGMVLIMISVQMFMNGLAGY-----
    192 UniRef50_C3WBK3        Integral membrane protein n...   111     3e-23  1  20.7%   5:217   8:206     ----VDAIFINALTLIAVLNPFGNVPLFIGMTEGMEKEIRNKLFKMIAITGFFITWIFSLFGEFLmnFYKINMNELKMAGGLILILMAIKNLIFSP-----QRKRTSEKQLSPDEQIKQAVIPMAFPMLVGPGSLTTALIGRSENGLTSN----------SFSILVAFIIIYLVLMVGNYLERIFGKLVLYILSKVMQIFIMSIGFRIFFDGLSHMI----
    193 UniRef50_B2J6W5        Multiple antibiotic resista...   110     4e-23  1  23.1%   4:219   2:197     ---DISILVQTFIAVFVLADAVGNIPIVLVLTKGMMPDQRNKVIDKAIIVAIAVLLLFAFAGQVILNYLEISIGSLRVAGGV------------LLLLIALQMLRGELDQPIIEEGRDVAITPLALPLLAGPGTLTTVMLLMSKSQSPH--------IAVAVGILGAMFITWLILRLANLIDQWIGAEGGVIVTQLLGFLLAALAVEIGSTGIRELFLS--
    194 UniRef50_A6Q130        Multiple antibiotic transpo...   109     7e-23  1  22.3%   4:218   5:213     ---FISILLHDIIALITIINPIAAASIMISMISPPTASAIADVARKATLTVFAASFVTLFGGEVVFQFFGINIYSIKIIGGIILMLIAINMAYGHGAKNRHSPEE----AQEAQEKEDIAIVPLGIPILFGPGVIATIVVLSHNNSSQLHPA--LSYILLSIAILIASLATYLTLRYASIINKALGVTGIKILTRIMGLIVGAIAAQFLISGIKGLWE---
    195 UniRef50_A4XNM2        Multiple antibiotic resista...   109     8e-23  1  21.4%   8:217   3:193     -------IFSIAVLIFLVTDPFGNIAIYIAALKNVAPRRRLWIAARELLFALGLLLLFLTFGDKFLSSLGLSREATAIAGGIILFVIAMRLIFPSPQGL-----------LGDVPDGEPMLVPLATPAVAGPSALAVLMTLRNTHTGPLWE--------LYLAVILAWAATAFILLQASFLQRFLGNRGLMAVERLMGMLLIMLSVDMLLDNLQSVF----
    196 UniRef50_Q9Y8Y7        Small neutral amino acid tr...   108     1e-22  1  20.2%   2:219   1:196     -MADLYTVVSSIILLFIVLDPVGVSPYVASIVARRPEGERERIVRTALASAGAILVAFTLIGVAVLDILGVSMDEFKVAAGLLLLIYATADLFEIKIGYSEP------------SGDEVAIFPLATPLLAGPGSIATVMYIMGS----------SGIAVALIAILVNLVLAYPILHASLKLVRLLGRHGSLLVAKFTAFLMVGFAVSIIFDGLRGIVPG--
    197 UniRef50_A5ETX6        Putative multiple antibioti...   108     1e-22  1  19.5%   1:221   1:198     MPSTLEFVITTFVTFFVVIDPLGILPIFMALTGKKSVAIRQQIAVRAVLLAGPILIVFAFAGDTVFRFLGISLPAFRIAG--VPADYGLQ-----PRPKKTRQSKARTWRFFHLQYRS-----------AGPGAMTSVILIMGKAGS-----DFLIQLIAMSTLLSVLLLCLLVFLFASRLMAVLGLTGVNVIGRVFGIVLAGLAIQYMLDGFAAYIAILK
    198 UniRef50_A7I7F8        Multiple antibiotic resista...   107     2e-22  1  23.3%   2:220   9:225     -MDQGTFFVTSLAALFAIINPVGNIPFFIMYTSEisPRTRQAVAVLLGPVIFVTVLLCMFFGSAVLSFFGVSMPAFEIAGAIILMIIALSMISGTRTEQVHAATSSETgwKAAEAYIPKIFIPLIFPIYIGGGTIAVSVLYGNDALTGG------FLAAAIGVTAIICIIIIACNLASDAITRVLGKQGLEIVARLVGVLLLGLAVQMFATGAGEMVATF-
    199 UniRef50_A1SUW5        Multiple antibiotic resista...   107     2e-22  1  19.4%   4:219   1:199     ---MLETFFTLYLKMFFMMTPFFVLSIFLSLSKKLSNPAKKVVILRSSIAVAVAGLIFLLFGKYIFSLFGITLDAFKIGAGTVLFLSALEMIKGGEVPENTMKKGS-----------DFAIVPLAIPSAIGPGLIGVLMVIGAE------MSGVLGITLVILSLLAAVISLAGVLLLSNKLQDLIGEQGLEIIPKITGLFVSAIGAQIIFSGIQGFLLQ--
    200 UniRef50_A1RZF3        Multiple antibiotic resista...   107     2e-22  1  19.7%   2:219  19:213     -VESLKELWDTFLMLFIVVDSIGNIPIFYSLTSGMGREERIKIFEKSVAVASALLVFFAVFGYPFFQYYGVSFTDFKI-------------AGGLLLLIIALQGVFGRVEAEALRSEDLAVVPMATPLLAGPGAIYMVMYLNS----------VYGLLPTLVSIALNTLASYLILTKSNVLLEKAGKNTILVLSRIFSLLLAVLAVSLIRSGIYEALRG--
    201 UniRef50_Q89Z73        Multiple antibiotic resista...   107     3e-22  1  20.9%  13:218  15:220     ------------MALFPVINPLGNGFVVNGFFADLDPSQRKTAIQKLTINFIMIGVGTLLIGHLFLLIFGLAIPVIQLGGGILICKTAIELL-GDSNSSDKEGTSQNVDSFKWKSIEQKIFYPITFPISIGPGSISVIFTLMASASVKGKLltGINYLVIALVIICMAGILYVFLSQGQRIIQKLGPVGNQIINKLVAFFTFCIGIQISVTGISQIFH---
    202 UniRef50_A7I5R8        Multiple antibiotic resista...   107     3e-22  1  18.9%   1:217   7:201     MTDIISGIIYAFAALFIILDPILSVPIFAGMTKGQSAREIHKQAFIAVAVAGILMYIFLVFNTAIFSVLGLTLSTFQIAGGILLFLLGMEMALGIDLCKSKEQVPTA------------AGVVIGTPLLCGPGAITTVMLLSNDY----------GILIPFIAISLSLAATWVILYYSAAIQNILGTVITDIMGRVLGMLVAGIAVKIIFSGIIGTL----
    203 UniRef50_C6X1I7        Multiple antibiotic resista...   107     3e-22  1  15.3%   5:220   7:195     ----LKETLTATMVLFAVIDIVGSIPIIVSLKKRFGHIE----AGKATLAAMFLMIAFLFIGNKILKFIGVDVNSFAIAGAIVIFIIALEMILGIEIHKNQ-------------EAKSASIVPIAFPLIAGAGTLTTTLSLKAEYHD----------INIICGIILNTLFVYLVLKSANWIERKLGEGTLQVLQKVFGIVLLAISIKLFTANFAQLFSSY-
    204 UniRef50_B9L924        Putative membrane protein n...   107     3e-22  1  20.9%   8:218   3:190     -------ILHIAVTLFLIMDPFGNFPVILSLLKDYNDKEKLQIIIRELIFAFVVIFIFIFFGKNIMNFLGLREESISIAGGIILFLIALKMIFPSSDPMFGKE-------------NELYLVPIAIPMIAGPSLLATLILFSSQYGISE----------VLGASLISWTLSALIIIISLKFSKIIPNRVFSAVEKLMGMLLISLSVQMLLDGIAKYLH---
    205 UniRef50_A3ZTD8        Putative uncharacterized pr...   106     5e-22  1  22.2%  16:218  14:202     ---------------IATIDPIGTLSIFVGVTGKSPKEDRPRIALKATLIGGAVLLAFLVLGQFILGALDIRLESFQLAGGLILFLLGLQMVFG---------VGPAVEAPKAEAGHDVAVFPLALPSIASPGSILAVVILTDNHR-----FTMLEQAVTAVVLVVVLGLTYVLMLAANPIHRLIGDTGGMIIVKVMGLLLCALATENCVEAVQQLWS---
    206 UniRef50_UPI000038253B COG2095: Multiple antibioti...   106     6e-22  1  27.7%   5:170  11:174     ----LTSFLLALSGLFSIVNPVGSALIFAQVTATRSQGERAELSRRIGFYAALVMLAALWAGAPILNFFGVSLAALRIAGGLFVAASAWTLLSAPETREARKHAEAAPESRE--NLAEIAFFPLTLPFTTGPGTIAVAIALGANRPSEPADLAAFFVGASLAALAIAGMV---------------------------------------------------
    207 UniRef50_Q6L037        Multiple antibiotic resista...   105     8e-22  1  24.0%  13:216   1:184     ------------MPLLVVIDPFGSLAIFVSMTASYNKDTKLSISRDAVLYGGMILIIFAALGEIIIQFFGISIEALEIAGGIILLLMGIEMVREGAKPESSSGSK------------NLGIVPFATPLLAGPGAISLVIILM--------KGSLTTKIFTIVSILIVLALVYIFFIFSSKILEILGEKIMTAITRIFGLLLAGFAIQYFLDALISL-----
    208 UniRef50_D0MK78        Multiple antibiotic resista...   105     1e-21  1  20.0%   5:219   1:197     ----MNAYLETFLPLFVAINLPGILPFFIALTEGLSAADRRRLLVRAVATAFVVAVLILFAGQLIFETLGITLNDLRVGGGLILLVLSITDLVFADYRRRDPRDGA--------DAADVGVVPLGIPLIIGPAAITTILVAQQTY----------GYLPTLVSLVANLLLVTAAFAAGPWVIRKLGPVAVRAIAKVASLFLAAIAVAMIRAGVAGMLAG--
    209 UniRef50_Q2LRX6        MarC family integral membra...   105     1e-21  1  20.7%   5:217   1:192     ----MKSFWLCFVPLFVAVDAVGILPLFMSLTEGLETRKLRRIISQSVITAIAVALVFLVLGKALMDLLGITIADFMVAGGILLFVISLNDVLA-----------TEKAQQHTVDPDSLGAVPLGVPLISGPAVLTTTLLLSNSY----------GFVPTATALILNILLAGGVFFSSRIIYRFLGKTGAKTISKITSLLLAAIAVMIIRRGLFIIL----
    210 UniRef50_A5GU87        Uncharacterized conserved m...   105     1e-21  1  24.5%   6:221   4:216     -----SSFQHYLIGLLAIGNNVSALGAFLLHTQGMPRAKVKRLILMSGLACLITLVLFMVVGTRILDFFGISVSAFQIAGGLLLGGVGLEMMnpLPTGAAASAAIPPAPDLSDAQFYSAAVVPIGIPLTIGAGTLSAVVLFAETAYRSGT------ALNLLGAILILVLVNTAIFRFSSRIMAWLGEVGVTIFIKLMGLFTLAIGVEFLTKGLGAIYLNLR
    211 UniRef50_B7K783        Multiple antibiotic resista...   104     2e-21  1  15.8%   7:221  91:293     ------SAFNLFIIFFVTLGPIKIIPTFVRLTQKADKNFRCQLAFISATISTIVIVFVAIIGQNILKVWQIRLPALMITGGILLFLVALKIVM-------SQYNLSPKAESPENPSLDLAINPLVFPTILPPFGIAIALTFMVMSPQLG-----ISSVITLALLLLVMGLNLICMLAAHPILSFIKPVTLLILGFILGVMQLALGIEFILSGLEIEVLVLQ
    212 UniRef50_Q6MDE1        Putative uncharacterized pr...   104     2e-21  1  16.8%   7:220   2:195     ------SVIQLAMIFFIVTNPIGNCPTIITLIKDYSIKQQQKILFRESIFSMILAILFLFLGEIFLTSFQIQNYALTISGGILLFIVALKMIFSDRLKTKTD-----------TPKQAPFIVPIATPLLSGAGLLTMIMLYSKEE---------ANDLKMLCAILLAWVGITTVLVTAPYLQIFLGKRGLAALEQLTGMLLAMIAIQMIVQGSGLFLTLL-
    213 UniRef50_Q3A045        Multiple antibiotic transpo...   104     2e-21  1  20.7%   4:220   6:203     ---FFTLLLHDALLLLAVINPLGNIPVYRDLTSGMDFSKRRAMIQLGVGTAAAMIIGFALLGDWSlnLFEVTLDEFRIAGGILLFIVAVRGVM----------TGSLSYNLLSDDFRTRAIFPLAFPIIVGPGTLAVTIILAQNRPP----------LHMLAVSSVSCIIVYLIASSAHSLMRVIGGYAAMIIPRLLYIFLAAKAVALIMHGLTGYVQGL-
    214 UniRef50_A5FMK4        Multiple antibiotic resista...   101     1e-20  1  20.7%   1:217   2:191     LEIDFKEIITVSMVLFAVIDIVGSIPIIVNLRAKVGHIE----SEKASIVAGAIMIVFLFVGEGLLNLIGIDVHSFAVAGSFVLFFLALEMILGIRIYR-------------DEEPGSASIVPLAFPLIAGAGTMTTLLSLRSQFHT----------INIITAIVLNIILVYIVLKSSKKIENLLGENGLGVVRKTFGVILLAIAVKLFAANVKGLF----
    215 UniRef50_B8HLY6        Multiple antibiotic resista...   100     3e-20  1  19.5%   1:210   1:202     MPDTSPTLSYVFTIFFLTLGPVKTISAFFRLTREANPKFRQRVALQAALISTAICLFIAFIGHNVLAKWGVSLEALRLAGGLILLLFALKVVMMQPQPSAGVQVTADT---PLPDTLKLAITPLSTPVIVTPYGVVAILFYMVIAQGYA-----VLQVQILGIVFLIMLLNYLGMIFADKIMNIIGMPILQLIGWIFAVMQSALAIDIML-----------
    216 UniRef50_C2M291        Putative membrane protein n...    99     1e-19  1  17.3%   5:218   3:189     ----LEHIAQISFKLFWIIDIIGGLPIFISLMNRFGKIQTEK----AALVSACLMIIFLFAGEAMLRFLDIPLKVFAVAGAFILFIIAVEMILGVSFHKM-------------EEANSISIVPIAFPLLAGPGVLTMILSLHSSY----------SSVDIVISILINVAIAYVVIKHCRRINDWMGQTGIVIANKIAGVILLALSIKMFADNWKTIFE---
    217 UniRef50_O84860        UPF0056 membrane protein CT...    99     1e-19  1  18.2%   4:217   1:196     ---MLHSLFRLTLLFYALFNALGSLPVFIALLKNFSFKKQQHIILRESIFALLLLLLFVTFGRGFFRLLGIILPAFQFTGSLLLGSIAIDMMKALPPQTETLER----------DKDEPIFFPLAFPVITGPAMITSTLGHMEE--------GIFPKKIVLGAIVLAWLFSLITLLLSSSINRLFGQMGLLALERLFGISLALMAGNLMLKALSTAF----
    218 UniRef50_C2M9S3        Multiple antibiotic resista...    99     1e-19  1  17.6%   5:220  17:207     ----LPSFFATFMILFVSIDIIGAIPIALSLKEKGKVFHPSKVA----IISAIMFMAFLFIGEPLLSFFGVDVSSFAVAGSIVLFVLAVEMIFGIQVFQDDDPSGNAD------------IVPLVFPLFAGAASFTAILTMRSSGTANST---------LFVAIILNVVCIYLMLRTVSLLERWLGKGGIYILRKFFGVVLLAISVKFFMQNLMIILEPF-
    219 UniRef50_Q607N5        MarC family integral membra...    99     1e-19  1  18.0%   7:217   2:193     ------TLAQVAVLLFLITDPFGNLPLLLTVLQRLGHAAYLRAVLRETAIAFVVLVVFAWKGDLLLGYLNVTQPSLNIAGGVILTIISLKMIFGGAQETFDDRYANDPLVVPIAIPAIAGPAAL-----------TTVMLLSKQQGIPFPT--------LFTALTLVFLANLTTFLLGRLLGEWLGPRGLTALERLMGLLLNLVAVDMTMAGIKRFF----
    220 UniRef50_C7LYJ4        Multiple antibiotic resista...    99     1e-19  1  29.4%   6:216   4:197     -----KFFVEALVTLLVIIDPIGNIPTFLVVTRGRDQRARRRLATEAVLVAAAVLAVFALAGSQILDYLGISIPALEVSGGLLLLIVALELLTGRGGSIGTT-----------EEGISVAVVPLATPLIAGPGAIAAVLVLAKRAATAP------LSVALAGALVGSMVILWVVLHYASALVRILKESGIALLSRVFGLLLAAIAVQLAAEGIRGF-----
    221 UniRef50_D0SM32        MarC family integral membra...    98     3e-19  1  19.4%   4:219   1:203     ---MFSPYIHAFALFFSLLNPFLMSVYMIGMIRNTDAKVFSKALIQGCLIAFIVFILFAWGGESIfrYLNVRFESFQIFGGLIFLVIGYRYVFQGAETIGEMRGAPEHLAGT-----------IAMPFMIGPGTISAAVVTGISVPFSGAVAVIAITLMLTCSILILMKFAHDHLRyaKYIDRYF-----DIVGRLSALLIGTIAVDMIVNGIMGLIES--
    222 UniRef50_UPI0001699175 multiple antibiotic resista...    97     4e-19  1  20.2%   7:179   8:169     ------EILSIAITLFLIMDPFGNIPVFLSILARVTEERRRVVLARELLLALVVILLFVFFGGTVMSLFGLSRAAVTIASGAILFLIALRLVFP-----------EKEAAADDEFEDEPLLVPLAVPLIAGPSLLAVLLVFTATEPDARGTLLIAALLAWLATSTILLASTFLYRVFSP------------------------------------------
    223 UniRef50_Q4C088        Multiple antibiotic resista...    97     5e-19  1  14.3%  12:214  83:274     -----------TIILFMTIGPIKIIPVFARLTQNASKQVIIKLATRSFALSTLSILTVALASENILNKYIISLSSLIVAAGIVLFLISLKMLL------QQYDNQKNNPLPIPENPLTALISPLTFPTILTPQGIALVMISMTIAQRLDNNVDK-----ILGLIMVVMILNLLSMLDARQILTVLQPILLQILNLILSIIQLALAISFMFSGIT-------
    224 UniRef50_C6HYD3        Multiple antibiotic resista...    95     1e-18  1  15.5%   5:217   1:196     ----MHTFWSVFLPLFVAIDPPGVLSIFFSLTQGVDIAQKRRTARSAVLTASLTVLFFDVFGTRLLDFLGLTLWDFT-------LAGGLLLLVLSVSDLLKNQDPETAGRPPGPFIGTLGPVPLGIPIIAGPATLTTSLIASKSASLAWALTALAA----------NMAILLAVLLAADRITRLLGAPLSAAVGKIFSLLLAAIAIHLIHRGIDGLL----
    225 UniRef50_Q467G3        Multiple antibiotic resista...    95     2e-18  1  19.5%  55:218   1:154     ------------------------------------------------------MPFFAVTSNIILELFSISVDSLRVVGEILLFSIAFDMMHAK----ISRESITEEDISQSQEREDIWVFPIGLPLLIGPGEISTVIVLMGSTENIEHKIIILISIIFTF------ILCLYIFLLSRRIHKFIGYNGMLVFTKLMGLLLAALAVNLTSAGLKNIFS---
    226 UniRef50_A1RTR6        Multiple antibiotic resista...    94     3e-18  1  19.2%   7:220   5:195     ------EFLGLVGQLYAIMNPIGKLAV-VGPLAVERPAYVRKITTVVIAVVYILAAIFAVSGGFILSAFGVSINSFRIAGGIVLMTISVTTLLSGSYVGR------------IEITEEHAVVPLATPLIVGPGTITALIVMSS----------IYGPLITLFIALTASTAVAITLIVGIRAVKYIGATPLRLVGRFMSLIIASVATEMILTGIRNYTQSL-
    227 UniRef50_D2ASF4        Putative uncharacterized pr...    94     3e-18  1  19.6%   4:217   1:215     ---MSHPALILFLALFGLYSPVAALASYLPIVRPYSHGQVNRLALGLAFNVAVFVLAALWVGEPLLKLLGISTAALTATGGIALAYASIPLMRGKAGAVEELEKLQEQDkePAPDPKSILYTPLTFPLTVGGTTFAFGVAASASAAGTQD------KIALSIAALCFAAVTGLTLYLSGHVQRRISLKGAMLLDRVAGILLTAIAVILLANGFTDLV----
    228 UniRef50_B1TBT7        Multiple antibiotic resista...    94     4e-18  1  20.0%  21:220  21:210     --------------------PPVAIPMYAAVTGHFPDATQRQIAFRLFAWIATLMVGAVWGGQFLLRMLGLTLGALTLTGGLVLCLWSIPMMRG----TANDERSGGDTRLEYAQWRNYIAVPLIFPLSIGSAVMSLVITTATRFHTP------VDLLALSAACILHAGVIGLTYACSASWCRRLGEIGRTLIERLSGIVLTAIAFQMLAQGVRELLPGL-
    229 UniRef50_B3T2F3        Putative MarC family integr...    94     4e-18  1  26.4%  55:217   1:155     ------------------------------------------------------MITFAYAGRYLLDAIGVSLDSLKIAGGIILMILAIDILFEKRKTRREKRV---EEALDEKSFDDIIVFPIAIPFIAGPAALTTIILLIGNYTINTEF-----QIPVILALIAALVVSLILMIGANFIVKFLPKQILHATARVMAFILAALATQFIIDGIKASF----
    230 UniRef50_D0ZDR8        Membrane efflux protein n=1...    94     4e-18  1  21.8%   1:220   1:211     METWLIHFLLTYVTFLSMFCPPATITAATILLGQTPPHTLRQLAWKVALEYVAVMLVAIWIGNYLLMALGLNAHALTATGGAALLFQGWPLM---TKGTKAEPARMVVTPDARPNVQDMVLVPLLFPLTIGGGTIAVGISLASH------DGSLAGLLQLSAVILLMAPTIALTFLAVGPLHGRLSSGAIDAMARIAGIVLVTLSLQLLASGLTQLVLQY-
    231 UniRef50_A8Z5R7        MarC family integral membra...    93     5e-18  1  15.9%  13:219   1:182     ------------MVLFSIIDVIGNAPIIIGYKNKGDIINPNQV----TLVSLGIFLFFIFLGNFILNTFGIDIYTFSLAGSIILFFISLEMILGIEFYKRDKSTSAQ-----------VSIIPISFPLIAGPGSVTTLMSLKKNYDMQT----------ILISLILNMIIVFFVIKKIDYIENNISNDNLNIIKKVFGIILLSYSIKLFGRNICNIFNT--
    232 UniRef50_B1WP37        Putative uncharacterized pr...    93     8e-18  1  14.9%  10:203  98:279     ---------NIFIIFFVTLGPIKIIPTFIKLTQNADDDLRKSLALNGAGLATIVIVLVVLIGGNILTRWTVSMSALLMAAGIMLFLASLQAVM-------SQYKGSAENEPLLEPSMKLLINPLTFPTILPPYGIALALILMVFNNRISDRP-----FIVPVMLILVMMLNLLAMLFARPILKTIKLPTLRIAGLVLGVMQLA------------------
    233 UniRef50_A6T440        Multiple antibiotic transpo...    91     2e-17  1  16.1%   4:214   1:198     ---MEEAYLRSFALFFALFNPFLMSIYLLDLIRGLPTPTFARVLIRGSVISACVFVLFAWGGEAFfdYLQVRFASFQIFGGIVFLLIGLRYVFSGAAAIESLRDNPTAMAGS-----------IAMPIMIGPGTVSAAVVIGTRLPLGGAAVVIVGTLILTVSILVAMKVAHDKLK---ERHAAMTDRYIDLVGRMSALLIGTIAIDMILTGLQ-------
    234 UniRef50_C9L1U4        MarC family integral membra...    91     2e-17  1  18.0%   5:221  22:212     ----WQQMVSAFIVLFAVI----DIIGSIPIIINLKERGKDVNAMKATVISFVLLIGFFYAGDMMLKLFHVDIESFAVAGAFVIFLMSLEMILDIEIFKNQGPIKEAT------------LVPLVFPLLAGAGAFTTLLSLRAEY----------ASVNIIIALVLNMIWVYFVVSMTGRVERFLGKGGIYIIRKFFGIILLAISVRLFTANITLLIEALH
    235 UniRef50_B3ET88        Putative uncharacterized pr...    91     3e-17  1  19.2%   5:207  13:189     ----IKKFLTAFFILFAVIDVLGCTAIIINMRNKIGYIH----ARKTATVAGVIMVTFLFLGQTILDLFSIDMSSFIIAGSIILFLLGLEMCLNISIFKTDTDANSS------------SIVPLAFPIIAGTGTLSTLLILRAECET----------INVLLASLVNLVLIFLVLKYSEWIEAKLGRLGVSIIHKMMGIILIAIAIK--------------
    236 UniRef50_D2PCH4        Multiple antibiotic resista...    91     4e-17  1  21.9%   2:216   1:199     -MSELVSIPEIAFKLYAIMDPLSILPYLIALYEEFNRNSQNKISwkLSIAVAVLLLFFSILGGPLLAFLGISVSALEIGGGIILVYLGVDTLGGFQQLKFLSSKI-----------EEAIITPIATPLIVGPGTMTGLITLSVSNNLIILILGSLLAALLVYLSLL----------LGPIIIRVLGNTGTVAVGRFMAIIIAAFGVQLIIDGISQI-----
    237 UniRef50_C7LK11        MarC family integral membra...    89     8e-17  1  13.8%   2:219   5:197     -LQQIKLFFTCFLILFSIIDIIGNAPIII----GYKKKGNIINTKKITLVSMLIFLFFFFLGDFFLNSFGIDLYSFSLAGSIILFLVSLEMIFEIDFSKLEKKSN-----------IEISIIPISFPLIAGPGSVTTLMSLKTNYDIKT----------IMLSLILNMIFVFFVIKNIDFIEKKISKSNLYIIKKLFGIILLSFSIKVFGRNVCNIFPN--
    238 UniRef50_A2SQL2        Multiple antibiotic resista...    89     1e-16  1  22.6%  42:218   3:168     -----------------------------------------RQAFVATGVAGVLMLTFLIFNNLLFDLLGIELESFKVAGGIILFILGLQIVLGLEIG-GSSAGHKSLESSDRIGKKSMAGVIIGTPVMCGPGTITTVMILGAQ----------DGIILTLVAVILALFCIWLILIFSAQIKKLLGETVLVILSKIVGLLLTAIAVHTIWTGILGLIA---
    239 UniRef50_Q5WGH6        Putative uncharacterized pr...    87     4e-16  1  15.1%   4:221   1:193     ---MVSFFIHAFVSIFAILYPIGNLSVRLGLAHIKGDTQRIHKAAKAILVVLGALTTLLLLEQWLLLLYNISIEAFTIGCGLCLLVIGCKLLQGKTRYRSKQKTIFATVASQ--------------------GAAGATMCLTANQNHR-----WFYVPITFLAFVSVLVLSLLPLLVANWLRGRTGQKGLSLVKRATGVALTVIAIEMVVMGFADILPSFE
    240 UniRef50_B5IJ45        Putative membrane efflux pr...    87     5e-16  1  18.7%   5:218   1:200     ----MEDLNRSVITLLALINPVICAVMLLERTPGVPHRRRLLLIGNVVLRTGLILLVSAAIGPQLLKRLGISLDVFQIVGGVVITSIGYGMFAPSPAPAAATGQESGSPENASLDPIVLFA--------ASPGTISTVLALSVMHGPDQGLLPTSLAVLIALAITAVVMAVMVLRPGAST------RSNSSLVSRFLGLILIAMGLQFVLTNLRTFFQ---
    241 UniRef50_A6C262        Putative uncharacterized pr...    86     1e-15  1  16.5%   5:216   1:199     ----MNDVFNSTALLLTLLNPFLVIIYLVDVVQKLEQKQFRHVLMRAGLITSAIFCSFVVLGDKIfgVMQVEFASFQIFGGIVFLLIGIQFVFKGPVVIEALRGESSNISAS-----------IAMPVLIGPGTISACVLIGKRHEPLVACTIVVISVFVCLATILVLK---FIHDMVNQKRSALIDRYIEIMGRITALYVGTVSIDMIMQGLRTW-----
    242 UniRef50_C5A3J5        Multiple antibiotic resista...    85     2e-15  1  19.9%   2:217   1:197     -MSEFSTILSSALLMLIMIDPSDKILLVSFLREDFHIEDIKALIVRANLIGFLLLASFAVAGQIIleIFHIDINALKVAGGFVLFKIGLEALEGGGMFTLKRER----------DILALAAVPVAMPLIAGPAAITAVITLTAEY----------GYLVSLSATAIAIAVVALSMFVALYMMKSVNKTFLSVTIRIIGLFIMAIGAQMMVEGVVGIY----
    243 UniRef50_C6B1S6        Multiple antibiotic resista...    84     3e-15  1  17.2%  19:216  22:206     ------------------MGPKIALVPFLEKTHAFDTQTKVRIGRQMVMIAVVTALILFATGALLMRLLHITGGAVAVAGGIILALIAIKMASG-------PIEKPHDDIAAPVDPDKLAVFPLAVPYLLNPVGITVIIIASGE------VVSITSAILVIGLILIVGALDYLVFTNIDKLAKRMKPVTMIVSEVVFGILLTAVAVQLIVVGLGNL-----
    244 UniRef50_D0SWE6        MarC family integral membra...    83     7e-15  1  15.8%   5:219   1:202     ----MSESLNAFALFFSLLNPFLMSIYMLGIIRNSDAKVFNMALIQGSLISFIVFIIFAKTGEAFFnvLHVRFESFQIFGGIIFLVIGYRYVFEGADTIGVMRGAPSHLAGT-----------IAMPFMIGPGTISASVITGIQLSLMQTILVIFSTLFLTCSLLILMK--YLHDHLQHKYSNYI-DLYVDIVGRVAALLIGTIAIDMIVTGVTGILET--
    245 UniRef50_A8M8X4        Multiple antibiotic resista...    82     1e-14  1  17.6%   9:218  10:195     --------LVAAVQLYAIIDPLGAIPLLVSV--PDYEKMMNKFLRLVAVTVPLLLLLFAFAGPFIFYVFSININDFRVAGGIILLIIAIDVL------------REGTPKTMGINPEDYVIVPIITPMLVGPGAITSVMVMVTYYN----------IFSVITAVLIASLATYITMKYSVYLVKLIGNNTLKIFARFFSLIIASWAIQLIASGIINIVK---
    246 UniRef50_B4B2T8        Multiple antibiotic resista...    79     8e-14  1  16.7%   8:216   4:201     -------LSSIFILLFITLGPLKTIIPFVELTAHSDEKLCRRVALRATFASTLVVLILGLLGPLILENWGVSLPAVSITGGIILFVGSLQVMMKPSESSGNKGVAPET------LSTSMLISRLVIPTIVTPPGIAAILALMVLSEKNQQLW-----LQIIGLLLLVMFLNLLIMLTARKLLAFLTVAGLRVIAWVFAVLQASLGAQVIINALRKL-----
    247 UniRef50_O57953        UPF0056 membrane protein PH...    78     2e-13  1  19.4%   4:220   1:198     ---MLKEILSSALLMLIMIDPSDKILLVSLLREDFHIEDVKSLIIRANLIGFILLLLFAVAGKIIldIFHIELDALRVAGGFVLFKIGLEALEGGGMVTIKREK----------NILALAAVPVATPLIAGPAAITAAITLTAEH----------GIIVSIVGTLIAIAITAALMMIALYLMRGISKTALSVTIRIIGLFIMAIGAQMMITGAGGIVLNL-
    248 UniRef50_B2S770        Multiple antibiotic resista...    76     6e-13  1  18.8%   2:219   1:204     -METGMIVGKLLPLLFNMMGPIGLMPIFAAMTVQMDKPTRNSVAARAAIFAALGILIAIFIGDPILRSWGISKPALILAAGVILTLSSIRAVLMPPAAPSQPAAAG--------DPKALAIRPLAFPTIVSPQGVGVLIIFVA------FLSSLSSTITILTVAGVIVLLDYGAMRIAHWFMATVGMVPLLVLGAVFGVLQVALGIEMMLSGLLLVLNS--
    249 UniRef50_A8U398        Multiple antibiotic resista...    72     9e-12  1  22.1%  99:220   3:117     --------------------------------------------------------------------------------------------------RSEVDDATATATYGDAQAIKVGVVPLGIPLMAGPGSFTAVILESQHSHSG-------GSLSVSLTIIGVAAVMWVLYLLAVPIARILGPIGLNIITRLFGLVVTAIGVEIIVRGIQTHVASF-
    250 UniRef50_D1BGR1        Cytochrome c biogenesis pro...    72     2e-11  1  18.5%  41:208 122:298     ----------------------------------------RRKSLRPYLVISGLVvfFTLLGSLILNALGLPQDLLRWVGLSLLAIIGVGMIVPRLEEIIERpaRQDRGAFLLGLGLGVLYVPCAGPVLA---AITVA---GATGNIGADTVALTVSFAVGAAIPLLIFALAG-RRVAERVGAFKRHtgIRIFGGVT-MILLAIGLAF-------------
    251 UniRef50_B4V0W4        Integral membrane C-type cy...    67     4e-10  1  15.5%  47:220 166:342     ----------------------------------------------AVVAGLVVSffFTLLGVTIISALGLPQDILRYLGLGLLVMIGLGLILPPVerIPQRQVNKEGSAFVLGLGLGLLYVPCAGPVLA---AITVA---GARGEISSGIVALTLSFALGTAIPLLVFALAGRRVSARVAAFRTRARGLRIAAGTL-MIVLAFALAfaTTALQRALPNY-
    252 UniRef50_Q0EYM7        Putative uncharacterized pr...    66     8e-10  1  17.8%  27:217   4:182     --------------------------YLLDLIQDLDRGTFFKVLFRATLISGSVFLVFAWGGDAIfdILQVQFSSFLIFGGIVIFIIALQMMFTGSDAIKKMRGGDPAHLSGS----------IAMPFMIGPGTISASVITGTTLSYPLALAAITLSLILTVLMLMVLKYAFDIIKV---RNADLLERYIDITGRASALLTGTIGVQMILQGIHKAL----
    253 UniRef50_A7BB75        Putative uncharacterized pr...    62     2e-08  1  15.2%  42:206  80:245     -----------------------------------------SVTRRPVLIVLGLVTSFmvAGSALLSLLNLPQALIRWTGIVLLMAVGIGMIIPkpFTRLAPRTTGDSAGFGLGLVLGAAFVPCAGPVL------TSIIVASSSGQITWHIVGLAISFAIGVSIPLMIVAIAGSGVAARFLKTR--QRPLRIAAGV-AMIALALGI---------------
    254 UniRef50_D0WLW3        Protein DipZ n=1 Tax=Actino...    61     3e-08  1  18.3%   4:172   2:178     ---FSQILIGLFGGLITGVSplPMLPifLAGATGASSDGkrKYPLLVTLGLVVSFTAVTLLGSTVLSLLGLPQDFIRWAGVAFLALIGVSLMIPKVerIRMKQVDKRSNGFVFGLVLGTAYVPCAGPVLA---AISVA---GSTGRVGAETAALAISFAVGVAVPLFFFALA-------------------------------------------------
    255 UniRef50_P59960        Protein dipZ n=22 Tax=Actin...    61     4e-08  1  15.8%  38:220 162:353     -------------------------------------AVRRKRALSATlvIGGLVLSFglLGSALLSVLHLPQDAIRWAALVALVAIGAGLIFPrfSRIPQKQIVTRSNGFGLGLALGVLYVPCAGPILA------AIVVAGATATIGLGTVVLTATFALGAALPLLFFA-----LAGQRIAERVgqREIRIAT---GSVTILLAVALVFdaLQRAIPDY-
    256 UniRef50_Q12GH3        Multiple antibiotic resista...    59     1e-07  1  18.5%  49:167  60:166     ------------------------------------------------VTARIVLLIFMVAGDRLLHAMRLTDASFEIAGGVILFLMAMGMAFPGMGVSLADSGHGG----------EPMLVPPAIPVITGPSALATVLLLAARQPDRG--WTWAAAIGLLLSAMAV------------------------------------------------------
    257 UniRef50_Q92Z96        Putative uncharacterized pr...    57     3e-07  1  19.1%  55:216   7:151     ------------------------------------------------------LAIAGLLGRTMLENFEISLPVLAMTGGIILFLVALRTVLHQSSSLPDQTTEPGQPSDLR-----LALTPLAFP------TILAVIVFATLAGGRQAEGRT-----VAAIVLLILAMDWAAMIFAESILRWIG-TSLQVLAVVLGVTQAALGLQIILHSLSTV-----
    258 UniRef50_A6FJM2        Putative uncharacterized pr...    52     2e-05  1  22.9%    1:70    1:70     MSQLFEHALTVFMAFFAIMNPIANTTVFAGLTGSMGKSEQVKIAVKSLTITFVIIVLFSILGKSIFHLFG-------------------------------------------------------------------------------------------------------------------------------------------------------
    259 UniRef50_D1K837        MarC family integral membra...    51     4e-05  1  22.7%  50:115    9:74     -------------------------------------------------ISFITLLAFTFSGQFLFKFFSISTNNFRIAASFIILKIGYDMLQARFTNTKLKNKEIKTYANDIPS----------------------------------------------------------------------------------------------------------
    260 UniRef50_C2CQB7        Integral membrane C family ...    46     7e-04  1  15.8%   1:171   1:173     MLSTLS--IGLVGGLVTGLSplPILPLVLAV-SGNGGRSRPWLVIGGLVTSFTAVTLFA---TTLLNALHLPGDLVWKVGIGLLVLVGLGMMFPKFQEILeqAKARDKGGFAVGLALGVVFVPCAGPVLA---AISVA---GATGTIDAHILILCLAFAVGVAIPLMAFAL--------------------------------------------------
    261 UniRef50_A2V4T5        Putative uncharacterized pr...    45     0.002  1  48.7% 179:217   28:66     ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------KPICKFMGKTGIDALTRIMGFLLVSMGMQFMINAVKDLL----
    262 UniRef50_Q8ZY52        Putative uncharacterized pr...    44     0.003  1  20.3%    7:80    5:77     ------EFLGLVGQLYAIMNPIGKLAI-VGPLAVEKPTYVRKITVVVIIAVYILSLIFALSGGLILAAFGVSLDSFRIAG---------------------------------------------------------------------------------------------------------------------------------------------
    263 UniRef50_Q255K2        Multiple antibiotic resista...    43     0.006  1  13.9%   2:217   1:201     -MDTMYLLFPQACILLLAADALTNVLALNCVLSNYSRKKRLSLLIRESLFALVSMFALYAAALGTLYVLKTPPCAIQVVGGIAVTLAGMRAIL--------NLNRENTWQGFASTSSLSLVTPIALPLMIGPSWLAACCILIGKRYSFTSISLILFLSWALISLTTIILQVFIG-------VGKEKTKVLLATQTVLGLFATIVGTQLLMSGLQLAF----
    264 UniRef50_B6R4W8        Phosphate transport system ...    41     0.026  1  14.7%   1:211 390:608     MAGIWGAAVGSFWTMLVTLspIGVAAAIY--LEEFAPKNRWTHLIEVNilAAVPSIVFGLLgaVFLNVFGLPRSA-PVVGGMVLALMTltIIIASRAALQAVPPSIREAALGVGASRLQAVfpLAMP-----GILTGTIIGMAQALGETAPLLMIGMVAFIVDIPasTVLPVQIFMWADFPEPAFQQKTSAAIMVLLGFLISMNAIAIVLR----------
    265 UniRef50_A6G157        Putative exported cytochrom...    41     0.031  1  17.2%   4:119 205:332     ---LFQFLVGSFIalLALLTpfPMIPITISFFAKHAEASRKKSLIMAGTYSGAIVVCFTILGVGASVIFgiPFNIFMF---LLLFVFGLSllFEISAPRFLIEKSSEMEQKYSEDEEAP------------------------------------------------------------------------------------------------------
    266 UniRef50_C4XRQ9        Thiol:disulfide interchange...    41     0.038  1  16.1%  29:202 403:577     ----------------------------LAISGEEGRQERRRILREHNFFFALGIVTYFLCLSLILGAFGmqSPSLAIVAAVVLFALALSlvFHLPVVDLKITSGGRGHTRRGAFLTGALATLLATPC-SGP--------FLGGVLAWTLLQPQHVIMTVFAAIGLGMASPYGVLAIWPRLVRLLPRPgmQSLERVMAFLLA-------------------
    267 UniRef50_A6V064        Thiol:disulfide interchange...    40     0.048  1  10.2%  44:210 354:514     -------------------------------------------AVLVCLALGAVLMALRALGSEIGWAFQLQNPAVILL--LILLTSAMGllFELGSLSAGSRLAGQDGPAGAFWTGGLAAfpCSGPFMAG--ALGAALVL-----------PPLAGLLVFAGLGFGLALPFLLLSFAPVLQGWLPRPgmQTLRRVLAILLFASAVWLVW-----------
    268 UniRef50_Q9VKA3        CG31860 n=3 Tax=Diptera Rep...    39     0.087  1   9.4%  42:212 303:473     -----------------------------------------KAARRVLIIACILCTIFlvIGGILSNSLAIATDAAHLLTDLASFLISISALHLAGRPSSERLNYGWHRAEVIGAMVSIFF----IWVVTG------ILVYMAIMRWVNQDFELDAKIMLITSALAILFNVIMAMQlsLPGVHKMSKDAGSVLGSKMILLLgsVSMQYAAKG---------
        consensus/100%                                                                                      .............................................................................................................................................................................................................................
        consensus/90%                                                                                       ..............hh.hhss...h.hhh.hh.t..........h...h..hhhhhh.hhhGt.hhthhtlt..shthsuuhhlh..uhthh............................h.PhshP.hhusushs.hh.h....................h.h.h..h..hh.h..s..h.thht..h..hh.ph.uhhh..huhthhh.sh.......
        consensus/80%                                                                                        ......hh..hh.hh.hhsPhs.hshhhshhtt.s.ttp.thhhh..hhshhhhhhhhhhGt.lhthhslshsshpluGGlllhhhuhphl.........................t..hhPluhPhhsGPuslsshhhh.tt.............h.hhhshhhhhhh.hhhhh.u..l.phls..sh.hht+lhuhllhsluhphhhtGh.th....
        consensus/70%                                                                                        ...h..hh.hhhhlhslhsPhushslahshstths.tpppphshpsslhshhlhhhhhhhGphllphhulolsuhpluGGlllhhhuhphl.s.......................phuhhPluhPhlsGPGslsshlhhtsph............hhhhhshhhhhhhshhhhhhuthl.chlGttuhtlls+lhGhllhslulphhhsGltthh...

MView 1.51.1, Copyright © 1997-2009 Nigel P. Brown